2022 Speakers

Dr. Abdul Ghani

Consultant Pathologist , Tawam Hospital | United Arab Emirates

Abdulghani Elomami consultant pathologist at Tawam Hospital, Al Ain, UAE since 2015 to date and Adjunct assistant professor at College of Medicine and Health sciences, United Arab Emirate University since 2016 to date. He was consultant pathologist at Red Deer Hospital, Alberta Health services from 2009 to 2015. He has done his residency training at the University of British Columbia, Vancouver-Canada in 2004 and passed FRCPC exam in 2008, after that he did one year fellowship at Vancouver General hospital and British Columbia Cancer Agency. He received Master degree in April 2000 after spent 4 years of training at Pathology Department, Garyounis University, Benghazi-Libya, passed the exams and prepared thesis “The Proliferation markers in serous tumors of ovary”. He worked as assistant professor for third year medical student at Medical College, Garyounis University and as histopathology staff in Central lab at the university from 2000 till 2003. He received his medical degree from Faculty of Medicine at AL-Arab Medical University - Libya in 1994

Prof. Abdul Rahman Jazieh

Director of Innovations and Research and Director of International Program , Cincinnati Cancer Advisors | USA

"Director of Innovations and Research and Director of International Program at Cincinnati Cancer Advisors, Cincinnati, OH, USA. Editor in Chief, Global Journal on Quality and Safety in Healthcare. Former Chairman and Professor, Department of Oncology and a Professor at King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. Former Professor and Chief of Hematology Oncology Division at University of Cincinnati. Founded the MENA-NCCN Collaborating Center (KSA) and the Association of VA Hematology Oncology (www.avaho.org) (USA). Specialized in hematology, and oncology with master’s Degree in public health in health education and communication. He published more than 100 articles, books, and book chapters. Dr. Jazieh won multiple honors including Proclamation to the City of Cincinnati, naming a day in the City as Dr. Abdul Rahman Jazieh Day in 2006 and Special Recognition from NCCN as Global Partner in Cancer Care 2018. "

Dr. Abdul Rahman Al Kinge

Medical Oncologist , Fakeeh University Hospital | United Arab Emirates

Dr. Abdul Rahman Agha El Kinge has an extensive experience in Medical Oncology. He has trained in Breast Cancer at the MD Anderson Cancer Center, USA, and he is also certified by the European Society of Medical Oncology. Dr. El Kinge is on the editorial board and a reviewer in multiple international medical journals. He is a Fellow of the American College of Physicians, and a member of local and international hematology and oncology societies. He has a keen interest in academics and as a result has multiple peer-reviewed publications. He has initiated and headed multiple oncology and hematology departments in KSA and UAE. He is the Chairperson of the yearly International Oncology and Supportive Care Congress. He has special interest and experience in Precision Medicine and Artificial intelligence in Cancer care.

Dr. Abdulla Al Sharm

Director of Comprehensive Cancer Center , King Fahad Medical City | Saudi Arabia

Dr. Abdullah Alsharm is the Director of comprehensive cancer center in King Fahad medical City, Assistant professor in King Saud bin Abdulaziz University for health science and Princess Norah University. Consultant medical oncology at comprehensive cancer center King Fahad Medical City, head of Scientific Committees in Saudi cancer institute and leader of cancer care in ministry of health , graduate from Queens University, Ontario, Canada in 2010, and medical oncology fellowship in gastrointestinal and genitourinary oncology from Queens University in 2011

Dr. Abdulla Alhasso

Consultant Clinical Oncologist , The Beatson West of Scotland Cancer Centre | United Arab Emirates

Dr Abdulla Alhasso has joined the Beatson Oncology Centre as a Clinical Oncologist with a special interest in Breast cancer and Urological malignancies. He is actively involved in the provision of clinical services in Clyde area as well as South Glasgow. This involves direct clinical care through outpatient clinics including follow up, new patients and chemotherapy clinics. He is also involved in the medical training and supervision for the junior Oncology team and take an active role in medical research and clinical trials.

Dr. Abdulrahman Sulaiman Bin Sumaida

Chief of Radiotherapy , Tawam Hospital | United Arab Emirates

Chief of Radiotherapy - Tawam Hospital

Dr. Adnan Hussain

Consultant Medical Oncologist , King Faisal Specialist Hospital and Research Center | Saudi Arabia

Dr Adnan Hussain works as a Consultant Medical Oncologist at King Faisal Specialist Hospital and Research Center, Jeddah. He has special interest in GI and GU malignancies He did his M.B.B.S from Dow Medical University, Karachi in 2001 after which he moved to UK in 2003 for further training. He did his core medical training and then specialist training in United Kingdom at Belfast Health and Social Care trust followed by which he joined Worcestershire Royal Hospital as a Consultant Medical Oncologist. He moved to KSA in 2015 and currently works at King Faisal Specialist Hospital and Research Center, Jeddah.

Dr. Aftab Ahmed Bhatti

Consultant Physician, Urology Clinic , Tawam Hospital | United Arab Emirates

Dr Aftab Ahmad Bhatti has recently joined Tawam Hospital as a Consultant Urological Surgeon, after working in the United Kingdom for more than 25 years. The main focus of his work is Urological Oncology, Minimally Invasive Robotic Surgery and Laparoscopic surgery. Dr Aftab A Bhatti graduated from the University of Punjab, Rawalpindi Medical College, Pakistan. He completed his higher urological training from the Northern Deanery, Newcastle upon Tyne, UK. Dr Aftab Bhatti has published over 40 peer reviewed publications and his area of research interest includes kidney and prostate cancer. the area of his interest includes active surveillance for the low risk prostate cancer, surgical anatomy of prostate, refinements to surgical techniques for robotic assisted radical prostatectomy and surgical outcomes of the high risk prostate cancer and prognostic markers for the kidney cancer.

Dr. Aladdin Marraoui

Consultant and Chief of Medical Oncology , Gulf International Cancer Centre | United Arab Emirates

Dr. Maarraoui is Consultant and Chief of Hematology/Oncology at Gulf International Cancer Center in Abu Dhabi and Clinical Professor at Gulf Medical University, UAE. He previously served as Chief of Hematology/Oncology at Mafraq Hospital for 14 years. He graduated from Faculty of Medicine at Aleppo University/Syria. He did his Internal Medicine residency at Christ Hospital and Medical Center in Chicago, and his Hematology/Oncology fellowship at the University of Colorado Health Science Center in Denver, Colorado. He is American Board Certified and recertified in Internal medicine in 1992, 2002 and 2012, in Medical Oncology in 1999,2009 and 2019 and in Hematology in 1999, 2009 and 2019. Dr. Maarraoui authored and co-authored several abstracts and articles on Breast Cancer, Colon Cancer, Thyroid Cancer, lung cancer and Lymphoma focusing on these diseases in UAE.

Dr. Aly Abdel Razek

Chairman and Executive Director , Gulf International Cancer Center | United Arab Emirates

Dr. Abdel Razek graduated from Cairo University. He completed his residency in 1976 at Washington University in St. Louis, Mo., USA. He is board certified in both Radiation Oncology and Pediatrics. He co-authored four text books in radiation oncology and contributed to many publications in oncology journals. He served on the national committee of the Southwest Oncology Group, Intergroup Ewings Sarcoma and National Wilms Tumor Committee. Dr. Abdel Razek is a Fellow of the American College of Radiation Oncology. He is president of Medical Resources International and Chairman and Executive Director of the Gulf International Cancer Center.

Dr. Amar Lal

Hematologist and Oncologist , Tawam Hospital | United Arab Emirates

"Dr. Amar Lal graduated from Dow University in 1993. He underwent medicine residency and followed by oncology fellowship. He qualified triple diploma in medicine, family medicine and oncology from CPSP Pakistan. Then he got triple diplomas from Royal Colleges of Physicians Ireland and Glasgow in medicine and speciality certificates oncology royal college London. He also qualified ESMO Examination Board in oncology. He has been local and international speaker in hematology and oncology and has more than 40 publications. He joined Tawam hospital in 2007 and he continued to be an active part of CME/ Scientific Program Coordinator, Member of Pharmacy & Therapeutics Committee (PTC), Patient safety physician manager, Member of Medication Utilization Committee (MSSC). "

Mr. Amjad Hussain

Radiation Oncology Medical Physicist , Tawam Hospital | United Arab Emirates

"Dr. Amjad Hussain is a Radiation Oncology Medical Physicist at Tawam Hospital, Al Ain since July 2022. He is also a certified Radiation Safety Officer (RSO). He received his Masters in Medical Physics from Pakistan Institute of Engineering and Applied Sciences, Islamabad, in 2003. In 2011 he graduated with a CAMPEP accredited Ph.D. degree from the University of Calgary, AB, Canada. Before joining Tawam, Dr. Hussain worked as a Senior Medical Physicist at CancerCare Manitoba, Canada Sr. Medical Physicist and Assistant Professor at the Aga Khan University Hospital (AKUH) in Pakistan. He did his post-doctoral fellowship from University of Calgary, AB. Dr. Hussain is a full member of the American Association of Physicists in Medicine (AAPM, since 2015) and a full member of the Canadian College of Physicists in Medicine (MCCPM, since 2016). He is the author of 23 scientific papers and 29 abstracts, published in reputable international journals. "

Dr. Amna AlHarrasi

Palliative Care and Cancer pain Consultant , Sultan Qaboos Comprehensive Cancer care and research center | Oman

Dr Amna Ahmed Al Harrasi, a Palliative Care and Cancer pain Consultant at Sultan Qaboos Comprehensive Cancer care and research center since September 2021. Dr Amna’s Educational background started with MD degree obtained from Sultan Qaboos University in 2010 followed by Postgraduate Residency in Family medicine from Oman Medical Specialty Board in 2015. Dr Amna developed special interest in the field of palliative care and pursued further qualification in Palliative care residency from McGill University from 2018-2019 followed by advanced study of Cancer pain fellowship from McGill University as well in 2019-2020. She worked in the field of primary care as family physician from 2015-2018. Dr Amna’s current clinical work is focused on palliative care and cancer pain management at Sultan Qaboos Comprehensive care and research center (2021-2022). Her initial research interest was general medicine and primary care. Her current interests are palliative care especially in gastrointestinal malignancies and cancer pain research. Dr Amna is a member of many international medical Societies including MASCC, EFIC, NCCN, ESMO and ASCO.

Dr. Anwar Al Nouri

Oncologist , Kuwait Cancer Control Centre | Kuwait

Dr. Anwar Al Nouri is an oncologist at Kuwait Cancer Control Centre

Dr. Aref Chehal

Adjunct Clinical Associate Professor of Medicine , Khalifa University | United Arab Emirates

Dr. Chehal is an Adjunct Clinical Associate Professor of Medicine, Gulf Medical University (GMU), Ajman, UAE Dr. Chehal is an Adjunct Clinical Associate Professor of Medicine, Khalifa University (KU), Abu Dhabi, UAE Dr. Chehal graduated from the college of Medicine at Baghdad University/Iraq (MBChB) in 1996. He did his Internal Medicine residency at Makassed General Hospital (Affiliated with American University of Beirut), Lebanon, between 1997 and 2000. He did his Hematology/Oncology fellowship at the American University of Beirut (AUBMC), Lebanon, between 2000 and 2003 (Lebanese Board). He obtained Fellowship of the American College of Physician (FACP) in 2013. He obtained the European Certification of Medical Oncology (ECMO) in 2009 and Re-certification in 2014 and 2021. Dr. Chehal is a member of many national and international societies including ASCO, ESMO, EHA,….. He had an important role in Tumor registry in Lebanon in 2002. Dr. Chehal acted as chairperson, moderator, advisor, and member of scientific committee in many local and international congresses. Dr. Chehal has 27 published articles in peer reviewed international journals; he is the first author on 9 of them, in addition to 31 abstracts. He joined Mafraq hospital From May 2006 until December 2019. He served as head of Hematology Oncology division at Mafraq Hospital from December 2018 till December 2019 His main interests are Lung cancer, Breast Cancer, GI malignancies and Lymphoma.

Dr. Arif Raza Alam

Chief of Hematology , Tawam Hospital | United Arab Emirates

Chief of Hematology – Tawam Hospital

Dr. Asif Quadri

Consultant Anatomical and Cyto-pathologist , NRL | United Arab Emirates

"Dr. Asif Quadri is a Consultant Anatomical and Cyto-pathologist, who joined NRL, after working as Consultant and Chief of Anatomical Pathology at Tawam Hospital, the Regional Cancer Centre in UAE for seven years. Prior to that, he worked as a Consultant Anatomical Pathologist for five years at City Hospital, Sandwell & West Birmingham NHS Trust, UK. Dr. Quadri’s special interests include biomarkers, gynecological pathology, breast pathology, lung tumors, genitourinary pathology, and soft tissue tumors. After completing his medical degree at the College of Medicine, the University of Baghdad in Iraq. Dr. Quadri pursued his pathology residency training in the UK. He was awarded a Certificate of Completion in Specialist Training (CCT) for Anatomical Pathology & Cytopathology from the Postgraduate Medical and Education Training Board and General Medical Council in the UK and a Fellow of the Royal College of Pathologists, London. His interest in Medical Education earned him a Postgraduate Certificate in Medical Education from the University of Staffordshire, also in the UK. Dr. Quadri is a College of American Pathologists (CAP) accreditation inspection team member. He is also a regional expert and trainer for companion diagnostic immunochemistry for PDL1 biomarker clones. He has been published in numerous professional journals and frequently presents cases and papers at local and regional meetings. "

Dr. Atif Iqbal

Associate Professor and Chief, Section of Colorectal Surgery , Baylor College of Medicine | United Arab Emirates

"Dr. Atif Iqbal earned his medical degree from King Edward Medical University and completed a surgical internship at Mayo Hospital, Pakistan. He then completed a surgical research fellowship at Creighton University Medical Center in Omaha, Nebraska, followed by a general surgery residency at the University of Missouri and a colon and rectal surgery fellowship at Washington University/Barnes-Jewish Hospital in St. Louis. He joined the University of Florida (UF) as an assistant professor in 2011 and was promoted to associate professor in 2018. Dr. Iqbal leads the Colorectal Surgery team, and specializes in surgical procedures for benign and malignant pathology of the colon, rectum and anus. He has a special interest in advanced laparoscopic and robotic surgical procedures for colon and rectal cancer, including sphincter saving procedures for low rectal cancer. He is a member of the Baylor Inflammatory Bowel Disease Center and offers laparoscopic pouch procedures for ulcerative colitis and minimally invasive surgery for Crohn’s disease."

Dr. Aydah Al Awadhi

Consultant Physician, Oncology Clinic , Tawam Hospital | United Arab Emirates

Dr. Aydah Al Awadhi is a Consultant Physician, Oncology Clinic at Tawam Hospital

Dr. Bertrand Tombal

Professor and Chairman , Cliniques universitaires Saint Luc | Belgium

"Bertrand Tombal is the Chairman of the Department of Surgery and Full Professor of Urology at the Université catholique de Louvain (UCL), Cliniques universitaires Saint-Luc, Brussels, Belgium. He is the Past President of the European Organization for Research and Treatment of Cancer (EORTC), the leading European academic research organization in the field of cancer. He has both a basic science and a clinical interest in urological oncology, particularly in the field of prostate and bladder cancer. Professor Tombal obtained his MD in 1990 and his PhD in 2003, both from the Université catholique de Louvain. During his PhD, he studied the mechanisms involved in apoptosis of prostate cancer cells and the modulation of apoptosis by growth factors. He completed part of his basic sciences training at Johns Hopkins University, Baltimore, MD, USA. Professor Tombal’s primary clinical interest is the treatment of advanced stages of prostate cancer, and particularly hormonal treatment and development of new biological agents. He is heading the urooncology division at the Université catholique de Louvain where he is coordinating several trials in this research area. In addition, Professor Tombal has authored more than 300 published papers, books, and book chapters. He has presented at numerous national and international conferences and has been the recipient of various awards for his research in the field of urology, including the European Association of Urology thesis award, which he received in 2003."

Dr. Brian Chaplin

Consultant Urologist , The James Cook University Hospital | United Kingdom

Mr Chaplin is a consultant urological surgeon; he has worked at James Cook, Middlesbrough and North Tees, Stockton hospitals since April 2011. He was a consultant from 2006-2011 at Bradford Teaching Hospitals and from 2004 to 2006 at Erasmus Medical Centre, Rotterdam, the Netherlands. Mr Chaplin has a special interest in oncological urology. He is especially interested in bladder, prostate and renal cancer. He regularly performs radical surgery for cancer using open and laparoscopic techniques. He has a specific interest in robotic minimally invasive surgery and has been involved in the implementation of the robot for robotic cystectomy since the first case done at James Cook in February 2015. He regularly performs robotic and open radical cystectomies, robotic prostatectomies, open and laparoscopic nephrectomies and nephroureterectomies. He contributes to national audit and research trials. He has presented posters and research data at national and international conferences. He was appointed in April 2017 as multi-disciplinary team lead for the urology cancer centre at James Cook.

Dr. Brian Weiss

Professor of Clinical Pediatrics , University of Cincinnati College of Medicine | USA

"Dr. Weiss specializes in caring for children with neuroblastoma and neurofibromatosis type 1 (NF1) related plexiform neurofibromas. He researches novel therapies and targeted radiotherapy to treat neuroblastoma, particularly high-risk neuroblastoma. He is also investigating the development of targeted therapies for NF1 related plexiform neurofibromas. "

Dr. Carlos Barrios

Director and Principal Investigator , Hospital São Lucas | Brazil

Dr. Carlos Barrios is the Director and Principal Investigator of the Oncology Research Center at Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul since 1996, where he has participated in more than 300 clinical research trials during the past 15 years. He is Director of Clinical Research and Oncologist of the Oncoclínicas Group in Porto Alegre. He is Adjunct Assistant Professor of the William Harrington Latin American Program of the University of Miami School of Medicine. He has a strong interest in the development of international research collaboration and implementation of cooperative research infrastructures in Latin America.

Prof. Daniel Palmer

Professor and Honorary Consultant in Medical Oncology , University of Liverpool | United Kingdom

Professor Palmer took his current position of North West Cancer Research Chair in Medical Oncology at the University of Liverpool in 2011. His research interests relate to HPB cancers (liver, pancreas and biliary tract) and incorporate basic laboratory science, translational research and clinical trials. His laboratory research is currently investigating novel therapeutic approaches to the treatment of HPB cancer through stimulation of anti-tumour immune responses and targeting tumour micro-environment including the tumour microbiome, and developing and validating biomarkers for a stratified approach to treatment. He is a member of the UK NCRN Upper GI cancers clinical studies group, and the hepatobiliary and pancreatic sub-groups. He is Director of the Cancer Research UK/NIHR Liverpool Experimental Cancer Medicine Centre and has established a portfolio of early phase clinical trials and translational studies and he is Chief Investigator for the TACE-3 and RaTIO trials investigating immunotherapy combinations for patients with intermediate and advanced HCC respectively.

Dr. Deborah Mukherjee

Consultant Medical Oncologist , Clemenceau Medical Center | United Arab Emirates

Dr Mukherji completed her advanced specialty training in Medical Oncology at Guys and St Thomas’s NHS Foundation Trust, London UK and was awarded a Post-Graduate Diploma in Oncology from the Institute of Cancer Research, University of London in 2011. Dr Deborah Mukherji joined the faculty of the American University of Beirut Medical Center in June 2012 as a medical oncologist with a special interest in genitourinary and gastrointestinal oncology and leads the Cancer In Conflict Workstream of the Research for Cancer in Conflict (R4HC MENA), is a Commissioner for the Lancet Commission on Women and Cancer and a faculty member for the European Society of Medical Oncology. Dr Mukherji recently joined the Clemenceau Medical Center Dubai as a consultant medical oncologist and continues her collaborative international academic and educational activities.

Ms. Deena Thomas

Acting Nurse Manager , Tawam Hospital | United Arab Emirates

Deena Thomas is working as Acting Nurse manager in hematology unit of Tawam Hospital with an overall experience of 22 years. She is an Oncology certified Nurse form Oncology Nursing Society (USA). She joined Tawam in - as a RN in Hematology unit. She has extensive experience and skills with various divisions within oncological care. She completed many Quality Improvement Project aimed at standardizing Clinical care. She is the Speaker of SEHA oncology Upskilling course. She completed the project regarding NCI toxicity management and presenting the poster on the 10th EOC 2022.

Dr. Diaeddine Trad

Consultant Physician, Oncology Clinic , Tawam Hospital | United Arab Emirates

Dr. Diaeddine Trad is a Consultant of Medical Oncology, at Tawam Hospital, in Al Ain, UAE. He is a member of the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is an investigator in several ongoing clinical trials. Dr. Trad is certified as a specialist in internal medicine, hematology and oncology by the Lebanese Ministry of Health. His research interests include; non-small cell lung adenocarcinoma and locally advanced breast cancer. Dr. Trad was a speaker in many international conferences and forums.

Dr. Dina Hamza

Consultant Medical Oncologist , Dubai Health Authority | United Arab Emirates

Consultant medical oncology Completed training in Oncology 2001 National Cancer Institute - Masters degree in clinical Oncology Cairo University - Fellowship from ULM university Germany - European Board certified from European school of Oncology worked in different health care systems Working in Dubai since 2008 Had more than 20 publications in oncology the most citation was for the MENA Breast Guidelines; acknowledged by e-cancer search foundation Member of the most dynamic, scientific and leading organization; EOS

Dr. Dinesh Chinchure

Senior Consultant in Department of Diagnostic Radiology , Khoo Teck Puat Hospital | Singapore

Dr. Dinesh Chinchure is a Senior Consultant in Department of Diagnostic Radiology, Khoo Teck Puat Hospital, Singapore. He is also Training Advisor, Quality Lead and Clinical Advisor (IT and PACS) in the department. Concurrently he holds the teaching posts of Clinical Senior Lecturer at YLL National University of Singapore (NUS) School of Medicine and Adjunct Senior Lecturer, LKC School of Medicine, NTU Singapore. He is also a Core Faculty in NHG Diagnostic Radiology Residency Programme. Dr. Dinesh is a member of the editorial board of journal Emergency Radiology, published by American Society of Emergency Radiology (ASER). He is a reviewer for several journals including Clinical Radiology.

Prof. Dirk Arnold

Director , Asklepios Tumorzentrum Hamburg | Germany

"Dirk Arnold is Director of the Asklepios Tumorzentrum Hamburg, a network cancer centre serving 7 community hospitals in Hamburg, and also Head of the department of Oncology, Haematology and Palliative Care at AK Altona, Hamburg. Before taking this position, he was 2010 appointed as Director of the University Cancer Centre in Hamburg (UCCH) and held positions at the University Departments for Oncology and Haematology in Halle-Wittenberg, Freiburg and Berlin. Between 2015 and 2017, he served as Director of the Instituto CUF de Oncologia in Lisbon, Portugal. His major field of scientific interest are gastrointestinal cancers, and here specifically modern therapeutic approaches in biomarker-driven decision processes, and multimodal treatment strategies, also including other specialities. Here, he has served as chairman of Colorectal Cancer Study Group of the German AIO, a major collaborative group in clinical oncology. Within the AIO framework, he served as founding member of the Central Clinical Trials Office, underlining his expertise also in methodology of clinical research. Furthermore, his interest is the organisation of larger collaborative research structures and of integrated cancer centre networks. Prof. Arnold is also member of the American Society of Clinical Oncology and Task Force Member of the National Cancer Institute, as well as Board member of the EORTC GI study group."

Dr. Dorai Ramanathan

Consultant Oncologist , Al Zahra Hospital | United Arab Emirates

Dr. Dorai Ramanathan is a highly qualified Oncologist from the United Kingdom with over 13 years’ experience in managing adult cancer patients alone. His expertise is both in Chemotherapy and Radiotherapy for all adult solid tumors. His sites of special interest are Breast, Lung, Gynaecological and Colon cancer.

Dr. Edward Black

Consultant - Thoracic Surgery , SEHA | United Arab Emirates

Dr Edward Black graduated from Guy’s Medical School, London in 1992. He trained in Cardiothoracic Surgery in Oxford, Leicester, Nottingham, Sheffield and Edinburgh. He was awarded Certificate of Completion of Specialist Training in Cardiothoracic Surgery in 2005. He is a Fellow of the Royal College of Surgeons of England in General Surgery and Cardiothoracic Surgery. He was appointed Consultant Thoracic Surgeon in Nottingham University Hospitals in 2006, Oxford University Hospitals in 2009 and SEHA in 2014. He currently works in SEHA-Mayo Clinic joint venture at SSMC Abu Dhabi and is Associate Professor at Khalifa University Medical School Abu Dhabi. He is Vice President of the Thoracic Surgery Group of the Emirates Respiratory Society.

Dr. Emad Dawoud

Consultant Physician, Oncology Clinic , Tawam Hospital | United Arab Emirates

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt. Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Dr. Emad Tashkandi

Medical Oncologist , King Abdullah Medical City | Saudi Arabia

Emad Tashkandi MBBS, ABIM, FRCPC, (Dip) ClinEpi is an Associate Professor at Umm AlQura University and Medical Oncologist at King Abdullah Medical City, Makkah, Saudi Arabia

Dr. Ernest Johan Luiten

Chief of Breast Cancer Center , Tawam Hospital | United Arab Emirates

Chief of Breast Cancer Center- Tawam Hospital

Dr. Fady Geara

Department Chair of Radiation Oncology , Cleveland Clinic Abu Dhabi | United Arab Emirates

"Dr. Fady Geara MD, PhD, is Department Chair of Radiation Oncology at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Geara served as Professor and Chairman of Radiation Oncology at the American University of Beirut Medical Center, Lebanon, after having been recruited from the University of Texas MD Anderson Cancer Center in Houston, Texas, US. Dr. Geara received his medical degree from the University of Paris XI, France, and completed his residency and fellowship at the University of Texas MD Anderson Cancer Center in Houston, Texas, US. Throughout his tenure, Dr. Geara has developed many state-of-the-art radiation oncology procedures. He developed the first high dose rate brachytherapy program in the Middle East, as well as the first Stereotactic Radiosurgery program. Over the years, Dr. Geara has become established as both a regional and international leader within his specialty. "

Dr. Fahad Ibnshamsah

Chairman of Adult Medical Oncology department , King Fahad Specialist Hospital | Saudi Arabia

Dr Fahad Ibnshamsah is a consultant in Medical Oncology. He is the Chairman of the Adult Medical Oncology Department, Oncology Centre, King Fahad Specialist Hospital in Damam. He is also the Director of Outreach Program in King Fahad Specialist Hospital and Assistant Professor of Internal Medicine at Imam Abdulrahman Bin Faisal University.

Dr. Faisal Azam

Consultant Medical Oncologist , King Fahad Specialist Hospital | Saudi Arabia

Dr Faisal Azam is a consultant medical oncologist at King Fahad specialist Hospital Dammam (KFSHD) and previously worked as a consultant at Betsi cadwaladr university board Hospital in United Kingdom. He has special interest in GU cancers, Gynae cancers, sarcomas and skin cancers. He had completed a formal training in Medical oncology at Clatterbridge cancer centre, Liverpool leading to a CCT and a research training at Oxford University. His qualifications include FRCP, CCT in medical oncology, MRCP-UK, MRCP-Ireland, PG-Dip in Oncology from Birmingham University and PG-Cert in Medical education from Edgehill Liverpool University. He is currently a research in-charge for Oncology, an IRB (Investigational review board) member and FTC (Formulary therapeutics committee) member at KFSHD. He has published more than 40 articles in peer-reviewed journals and did presentations in many international, national and regional oncology conferences.

Dr. Faisal Al Terkait

Medical Oncologist , Kuwait Cancer Control Center | Kuwait

"Medical oncologist in Kuwait cancer control center from 2012, Head of breast unit from 2017 to 2021, inaugurated the first medical oncology departments outside kccc in Kuwait. Currently Head of Medical oncology department at Jaber al-Ahmad hospital in Kuwait. MRCP UK. MBBS UK. CCST ONCOLOGY UK "

Dr. Faraz Khan

Head Of Hematology Program , American Hospital | United Arab Emirates

Asst Prof Dr. Faraz Khan is a Consultant Hematologist and Medical Oncologist with over 15 years experience in treating cancer and various blood diseases. He completed his Internal Medicine, Hematology and Medical oncology training from the University of Connecticut, CT, USA and is triple board certified in Internal medicine, Hematology and Medical Oncology. He worked as a consultant Hematologist/Medical Oncologist at PEI Cancer Treatment Center, PE, Canada and directed the provincial hemophilia and bleeding disorder clinic.

Dr. Fathi Azribi

Consultant Medical Oncologist , American Hospital Dubai | United Arab Emirates

Dr Fathi Azribi is a Consultant Medical Oncologist. He graduated from Tripoli University, Libya, then completed specialty training in Oncology in the UK and obtained a Certificate of Completion of Training in Medical Oncology. His main interest is in thoracic, breast, gynaecological and gastrointestinal malignancies, with expertise in treatment with chemotherapy, immunotherapy, hormonal, and targeted therapy. He published several papers and abstracts in peer reviewed journals. He also founded the first Medical Oncology Fellowship program in the UAE.

Dr. Gelareh Zadeh

Professor , University of Toronto | Canada

"Dr Gelareh Zadeh is a Professor at the Department of Surgery University of Toronto. She is a Neurosurgeon-Scientist at Toronto Western Hospital, University Health Network. She was most recently appointed as the Wilkins Family Chair in Brain Tumor Research. Her clinical practice focuses on Skull Base Neuro-oncology, with dedicated general brain tumour clinic and many multidisciplinary clinics that she has established and is actively involved with such as skull base, pituitary, brain metastases, gamma knife and neurofibromatosis clinic. She is actively involved with and is dedicated to the goal of advancing surgical clinical trials. Her research laboratory is focused on studying the molecular mechanisms of glioma angiogenesis and molecular regulators of tumour metabolism. Specifically investigating the role of bone marrow derived cells in supporting tumour vasculature in gliomas and how differentiation into macrophage and microglia population plays a role in escape mechanisms of evading anti-angiogenic therapy. A second focus of the laboratory, on tumour metabolism, explores the interplay between altered metabolism in response to anti-angiogenic therapy. She also has a translational program, dedicated to establishing the genomic landscape of menigniomas and schwannomas. Her laboratory is funded through peer-reviewed grants from a number of agencies such as CIHR, Terry Fox New Investigator grant, CCSRI, CRS, BrainChild and others. She is a scientist at Labatts Brain Tumor Research at Sick Kids Research Institute and Macfeeters-Hamilton Neuro-oncology Centre at Ontario Cancer Institute. She is active in many local, national and international committees in the field of neuro-oncology. She is the director of the UHN brain tumor bank and co-director of the University of Toronto Brain Tumor Bank. Together with Dr Vera Bril she is the co-Director of the UHN Elizabeth Raab Neurofibromatosis Program. She is the Chair of Academic Affairs for Division of Neurosurgery at University of Toronto. She has served as the scientific co-chair of Society of Neuro-oncology for two years (2014 and 2015), she is currently the Secretary/Treasurer of Society of Neuro-oncology (2016 & 17) and Chairof Neuro-oncology Committee at the World Federation of Neurological Surgeons (2013-17). She is the co-chair and founder of the consortium on meningiomas, in collaboration with Society of Neuro-oncology."

Prof. Giovanni Martinelli

Associate Professor , University of Bologna | Italy

Prof. Giovanni Martinelli Scientific Director Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl – IRCCS - Italy. His research and clinical activity involve the area of acute and chronic myeloid leukemia (AML and CML), acute lymphoblastic leukemia (ALL) and myelodisplastic syndromes (MDS). His expertise is in Conduction of several Phase I-II-III clinical trials and biological research projects on AML, ALL, MDS and CML as Principal Investigator, with good knowledge of Good Clinical Practice. He has the skills, expertise and authority to lead a team and he has the capacity of using the resources in a flexible way, to achieve the project objectives.

Dr. Guido Hein Huib Mannaerts

Chair of Surgery Department , Tawam Hospital | United Arab Emirates

Dr Mannaerts, a double Dutch board certified Gastro-intestinal as well as Oncology surgeon, is the Chair of Surgery Department in Tawam Hospital (UAE). He is the director of the high volume bariatric center in Tawam Hospital, which has with 750 cases in 2017 done the highest annual number of cases in the Gulf region. Besides that he is the lead of the surgical oncology unit in Tawam Hospital. He is known from the international fast-track bariatric courses in Rotterdam, The Netherlands, and is the lead investigator in multiple large randomised controlled trials, leading to over 70 Pubmed registered publications. He has performed a PhD on the multimodal treatment of locally advanced rectal and locally recurrent rectal cancer (ISBN 90-367-1418-4).

Dr. Guillermo de Velasco

Associate Professor in Hematology , University Hospital 12 de Octubre | Spain

"Guillermo de Velasco, MD PhD, is a medical oncologist with special interest in GU tumors. Dr. de Velasco received his medical degree from Complutense University, Madrid (Spain) in 2006. In 2011, Dr. de Velasco completed his residency training in Medical Oncology at the University Hospital 12 de Octubre. During the last two years of his fellowship, he also obtained a Master degree in Molecular Oncology at CNIO, Madrid (Spain). After finishing his Oncology fellowship in Spain, Dr. de Velasco was awarded with an ESMO fellowship to work in the Genitourinary Department at Cambridge University (UK)--nder the directorship of Professor Tim Eisen. While there, he also developed research in Christian Frezza’s Lab to explore metabolomics signatures in kidney cancer. In 2015, Dr. de Velasco was awarded with a SEOM fellowship to join the Dana-Farber/Harvard Cancer Center, as a research fellow with Professor Toni K. Choueiri, where he was involved in several clinical and translation investigations in the Genitourinary field. Dr. de Velasco is currently an independent clinical researcher and attending physician at University Hospital 12 de Octubre. His research focuses on understanding mechanism of response and resistance to different treatments in in renal cell carcinoma and other GU malignancies "

Dr. Hani Osman

Consultant Oncologist , Tawam Hospital | United Arab Emirates

"Dr. Hani Yousif Osman graduated from the Faculty of the Medicine University of Khartoum Sudan. He moved to the United Kingdom where he completed his training in internal medicine and obtained his MRCP (UK) degree, Fellowship from the Royal college of pathologists and CCT. He completed his high specialist training in hematology at the University of Cardiff hospital UK. His research focuses on acute myeloid leukemia novel therapy, He has extensive hematology consultant experience in the UK, Saudia Arabia, and the United Arab Emirates. Dr. Osman was involved and the principle investigator for many clinical trials and he has over 30 publications.

Dr. Hassan Ghazal

Consultant Medical Oncologist & Consultant Clinical Hematologist , King's College Hospital London | United Arab Emirates

"Dr Hassan Ghazal is an American board-certified Consultant Medical Oncologist and a Consultant Clinical hematologist offering more than 3 decades of clinical experience. Dr Hassan Ghazal, after doing his basic medical education in American University of Beirut, moved to US for his residency program in Internal Medicine at Sinai Hospital of Baltimore, MD. In 1992, completing the residency program, Dr Hassan Ghazal joined in George Washington university Medical Center for his fellowship in Medical Oncology and completed the same in 1995. He continued in George Washington University Medical Center for another 2 years and obtained his senior fellowship in bone marrow transplantation in the year 1997. He got his US board certification in Internal Medicine, Medical Oncology and in Hematology in the year 1992, 1995,1996 respectively. Except his association with CMC for the preceding 3 years, all his clinical practices were in US in various capacities including Director, Kentucky Cancer Clinic and Staff Oncologist/ Hematologist at Hazard Appalachian Regional Medical Center. Dr Hassan Ghazal is a member of various clinical societies such as American College of Physicians, American Society of Haematology, American Society of Clinical Oncology, European Society of Medical Oncology etc. Dr Hassan Ghazal has got many publications and abstracts in his credit, in peer reviewed journals, and there are many international recognitions and accolades in his name. He has been involved in numerous clinical trials, nearly 100, in the US, serving as Principal Investigator, for over 25 years, and enrolled hundreds of patients in these trials."

Dr. Hassan Jaafar

Medical Oncology Consultant , Burjeel Speciality Hospital | United Arab Emirates

Dr. Hassan Jaafar is a consultant medical oncologist with more than 25 years of professional experience. He commenced his career in Internal Medicine in 1994 and ultimately qualified in oncology/hematology in the year 2000 from the American University of Beirut Medical Centre. Later that year, Dr. Jaafar relocated to the UAE and joined Tawam Hospital, a 500+ bed, tertiary-care hospital, affiliated with the reputed Johns Hopkins University Hospital in the USA. During that time, he served as an adjunct Assistant Professor of Internal Medicine at the College of Medicine and Health – UAEU. He later relocated to Sheikh Khalifa Specialty Hospital (SKSH) operated by Seoul National University Hospital (SNUH) in Ras-Al-Khaimah. With his arrival at BCI as a Consultant Medical Oncologist, Dr. Jaafar moves up yet another notch in his career to be rated as one of the frontline oncologists and cancer research specialists in the UAE region. Major areas of clinical and research interest include breast cancer and gynecological cancers, lung cancer, colorectal cancer, sarcomas, and other solid tumors. Dr. Jaafar worked on multiple publications in esteemed journals and has a plethora of abstracts and cases presented at conferences around the world. Below is a brief sample of his publications.

Prof. Hennie Botha

Professor and Head of Department of Obstetrics and Gynaecology , Stellenbosch University | South Africa

Hennie Botha is Professor and Head of Department of Obstetrics and Gynaecology at Stellenbosch University of and Tygerberg Hospital in South Africa. He started his professional career in a rural hospital in Malawi. Returning to South Africa he specialised in Obstetrics and Gynaecology and then did further training in the field of Gynaecological Oncology in the United Kingdom. He has authored or co-authored many articles in journals and is co-editor of the textbook “Clinical Gynaecology”. His research focus is on cervical cancer prevention and treatment, including in people living with HIV. He collaborates with national and international researchers. He served on the council of the International Gynaecological Cancer Society and is International vice-chair of the HV Group of the AIDS malignancy consortium. Prof Botha is enthusiastic about under-and postgraduate teaching and training and his unit has trained many specialists and sub-specialists in South Africa and other African countries.

Dr. Hidayath Ansari

Consultant Radiologist , Cleveland Clinic | United Arab Emirates

"Dr. Hidayath Ali Ansari is Consultant Radiologist, Chief of Nuclear Medicine at the Imaging Institute of Cleveland Clinic Abu Dhabi and Medical Director of Cleveland Clinic Abu Dhabi ( AlAin Branch). Prior to his career in UAE; Dr. Ansari worked as a Consultant Radiologist and Clinical Director for the Department of Radiology at the University Hospitals of Morecambe Bay (NHS) Trust in Lancaster, UK and as Chair of the Radiology, Lancashire Cancer Network. He completed his residency and Fellowships in Specialist Radiology Training at Manchester with PET-CT fellowship at the University Hospital Zurich in Switzerland. His areas of Specialist Expertise include PETCT, Nuclear medicine, CT Colonography and MR Enterography. He has worked with his team to establish Cardiac blood flow quantification, American College of Radiology accreditation, contrast enhanced PETCT and new isotope services including DAT Imaging for Parkinsonism, Sentinel node mapping and hybrid imaging amongst few recent achievements and are working towards establishing Gallium PETCT for prostate and Neuro endocrine tumors. He has been recently awarded Clinical Excellence award for 2019 for recognition of his contribution. He is a fellow of Royal College of Radiologists, actively involved in education and research. He received Four NHS Clinical Excellence Awards from University Hospitals Morecambe Bay NHS in-between 2009 and 2014 in recognition of exceptional contributions to patient safety, quality of clinical care and education. "

Dr. Husam Marashi

Consultant Clinical Oncologist , Beatson West of Scotland Cancer Centre | United Kingdom

Dr Husam Marashi is a Consultant Clinical Oncologist based at the Beatson West of Scotland Cancer Centre and Rosshall Hospital. He underwent post graduate training at the West of Scotland hospitals and became a consultant in 2015. He developed a special interest in the non-surgical management of Upper gastro-intestinal and Breast malignancies including chemotherapy, radiotherapy, targeted therapy and immunotherapy. He is a principle investigator for many clinical trials and involved in many precision medicine programmes. He is also an active member of the oligometastasis SABR radiotherapy team. Dr Marashi has an active role in medical education/training for clinical oncology trainees in Scotland, and a member of RCR recruitment team. He is a member of the breast cancer MCN advisory board for the West of Scotland.

Dr. Hussain Aby Ali

Consultant Radiologist , Tawam Hospital | United Arab Emirates

Dr. Hussain Aby Ali is consultant Radiologist at Tawam Hospital since 2016 - Chief of diagnostic radiology 2022-till present - Physician lead 2020-2022 - Deputy Chair of radiology dep 2018-2020 - Chair of head and neck MDT 2020-till present Graduated from Jordan University of Science and Technology as a Doctor of medicine –Jordan, 2006 Master degree from Jordan University of Science and Technology in diagnostic radiology 2011 Arab Board in radiology and medical imaging 2012 Oncology imaging fellowship from King Hussein Cancer Center (KHCC) 2013 Specialist Radiologist in KHCC 2013-2014 Consultant Radiologist in KHCC 2014-2016 with interventional experience for 1 year. Joined Tawam hospital in 2016 as head of CT section and becomes a deputy in 2018-2020. In 2020, becomes the chair of head and neck MDT meeting till present. In 2022, becomes the chief of diagnostic radiology till present. In 2020, becomes the main radiologist covering the chest MDT. His main interest is oncology imaging, chest, neuroradiology and head and neck radiology.

Dr. Ignacio Gil-Bazo

Head of the Department of Oncology , Valencian Institute of Oncology | Spain

"Prof. Gil-Bazo is the Head of the Department of Oncology and Scientific Director of the Valencian Institute of Oncology (IVO) in the city of Valencia, Spain. He has previously served as Chairman of the Department of Oncology at the University of Navarra, in Pamplona, Spain. In addition, he is Associate Professor of Medicine at the Department of Oncology at the University of Navarra School of Medicine and Director of the New Therapeutic Targets Laboratory of the Program in Solid Tumors at the Center for Applied Medical Research (CIMA). Prof. Gil-Bazo is a Medical Oncologist with expertise in Thoracic Oncology, Translational Research in Oncology and Clinical Investigation. The Valencian Institute of Oncology (IVO), an OECI accredited Cancer Center, is a nationally and internationally renowned institution, the largest and most prestigious private cancer center in Spain."

Dr. Ikram Burney

Senior Consultant in Medical Oncology , Sultan Qaboos University Hospital | Oman

"Dr. Ikram Burney is a Senior Consultant in Medical Oncology at Sultan Qaboos University Hospital (SQUH). He graduated from Pakistan and received his training in Medical Oncology at the Aga Khan University in Karachi, Hammersmith Hospital in London, and Southampton University Hospital. He has been working at SQUH since 2003 and his area of interest includes Lymphoproliferative disorders, Gynecological malignancies, Sarcoma and Melanoma, and Supportive care in Oncology. He has more than 90 publications in peer-reviewed journals."

Ms. Iman Al Ameri

Psychologist , Tawam Hospital | United Arab Emirates

Iman Hashem Al Ameri has been working as a psychologist in Tawam Hospital Oncology Centre since 2012. She received the Bachelor degree in psychology in 2009 from the United Arab Emirates University and her Post Graduation Professional Clinical Diploma in Applied Psychological Skills and Competencies in Mental Health in 2014 from the College of Medicine at the United Arab Emirates University in Al Ain.

Dr. Jamal Alkoteesh

Consultant and chief of Interventional Radiology , Tawam & Alain Hospitals | United Arab Emirates

"Dr Jamal ALkoteesh is one of the founder of Interventional Radiology speciality in UAE and he is the longest served (15 YEARS) Interventional Radiologist in SEHA/Abu Dhabi Emirates .He was the first DOH licensed Interventional Radiologists in Abu Dhabi Emirates. Dr. ALkoteesh started working in SEHA as the chief of Interventional Radiology at Sheikh Khalifa Medical city between 2007-2010 where he also managed and established the first Radiology Residency Program in Abu Dhabi Emirate and become the first Radiology residency program director in 2009 when took the challenge to train UAE junior doctors to become the Radiologists of the future. "

Dr. Jamila Riromar

Consultant Medical Oncologist , National Oncology Center | Oman

"Dr Jamila Rir Omar is a consultant medical oncologist with special inters in improving metastatic cancer patient’s outcomes. She has joined genitourinary + gynecology subspeciality, in National Oncology Center Muscat, Sultanate of Oman since September 2019. She has obtained 2 years fellowship program in Genitourinary medical oncology from university of Toronto Canada, May 2017- June 2019. She has completed 5 years speciality residency program in medical oncology from university Claude Bernard Lyon 1, republic of France with DES French board in medical oncology. She completed internal medicine training program from Oman Medical Speciality Board (OMSB) in august 2009 with MRCP-UK February 2009."

Dr. Jawaher Ali Ansari

Acting Chief, Oncology Clinic , Tawam Hospital | United Arab Emirates

Dr Jawaher Ansari completed his Clinical Oncology specialist training in Birmingham, UK and worked as a Consultant at the Beatson Cancer Centre in Glasgow, the second largest cancer center in the UK, prior to moving to the Middle East. Dr Ansari has been a principal investigator for several international clinical trials and has authored several peer-reviewed publications and textbook chapters. He has a specialist interest in Urology, Breast and Lung cancers.

Dr. Jehad Abdullah

Consultant infectious disease , Sheikh Khalifa Medical city | United Arab Emirates

Dr. Jehad Abdalla, M.D. is an American board-certified in both Internal Medicine and Infectious Diseases, currently works as an Infectious Diseases consultant at Al Rahba hospital in Abu Dhabi, head of the infection control and prevention committee and chairperson of antibiotic stewardship program and at Al Rahba hospital. Dr. Abdalla has a special interest in Tuberculosis as well as HIV management.

Dr. Jeremy Rubinstein

Assistant Professor of Pediatrics , University of Cincinnati College of Medicine | USA

Dr. Rubinstein specializes in treating pediatric leukemia and lymphoma, emphasizing the use of cellular therapy. His research focuses on using new a+O48nd emerging cellular therapy techniques to better treat difficult-to-manage leukemias and lymphomas and the management of important side effects such as viral infections

Dr. Johan F Vansteenkiste

Professor of Internal Medicine , Catholic University of Leuven | Belgium

"Johan F. Vansteenkiste is a Professor of Internal Medicine in the Faculty of Medicine at the Catholic University of Leuven, Belgium, and Head of Clinic in the Respiratory Oncology Unit and its Clinical Trial Unit at the Leuven University Hospital, Belgium. Professor Vansteenkiste studied Medicine at the Catholic University of Leuven before becoming a Board Certified Pulmonologist-Oncologist. He had additional training in Respiratory Oncology at the European School of Oncology in Milan, Italy, and in Respiratory Endoscopy at the Laser entre in Marseille, France, before gaining his Ph.D. at the Catholic University of Leuven in 1996. Professor Vansteenkiste is an active member of different national and international societies such as IASLC, ASCO, ESMO, ERS, and others. He is a member of the Board of Directors of IASLC from 2009-to 2013 and a member of the ESMO Lung Educational Group and Guidelines Group. He was Secretary of the Thoracic Oncology Assembly of the ERS and a member of the ERS School Board from 2009-to 2012. He is the principal investigator or co-investigator in several clinical trials in the area of lung cancer. He is an Associate Editor at the Journal of Thoracic Oncology, a member of the editorial board of the Journal of Clinical Oncology and several other journals, and author or co-author of more than 200 peer-reviewed papers and book chapters on Respiratory Oncology."

Dr. Joseph Pressey

Professor of Clinical Pediatrics , University of Cincinnati College of Medicine | USA

Dr. Pressey joined the Cancer and Blood Diseases Institute at Cincinnati Children's to direct the Sarcoma and Young Adult Oncology Programs in 2014. He is appointed Professor of Clinical Pediatrics at the University of Cincinnati College of Medicine and functions as the Cincinnati Children's Institutional PI for the COG Pediatric Early Phase Clinical Trials Network (PEP-CTN) and SARC, as well as, for many industry-sponsored trials.

Dr. Justin Sanders

Associate Professor of Family Medicine , McGill University | Canada

Dr. Justin Sanders is the Kappy and Eric M. Flanders Chair of Palliative Care, Director of Palliative Care, and Associate Professor of Family Medicine at McGill University. Dr. Sanders qualitative and mixed-methods research focuses on cross-cultural serious illness communication and authentic healing relationships in order to drive quality and equity in the care of those affected by advanced cancer and other serious illnesses. Dr. Sanders completed fellowship training in Palliative Care at Massachusetts General Hospital and the Dana-Farber Cancer Institute in 2014, where he remained on the faculty at Harvard Medical School until 2021. As an associate faculty member at Ariadne Labs, a health systems innovation center at the Brigham and Women's Hospital and the Harvard T.H. Chan School of Public Health, Dr. Sanders continues to work on system level approaches to improving serious illness communication and care.

Ms. Kanaga Murugan

Oncology Clinical Educator , Tawam Hospital | United Arab Emirates

"Kanaga Murugan is working as Clinical Nurse Educator for Adult Oncology Division in Tawam Hospital with an overall experience of 22 ys both in Clinical as well as Teaching. She received her Master’s degree in Hospital Administration 2017 from Jaipur University, India. She joined Tawam in March 2009 as a RN in Oncology unit. She has extensive experience and skills with various divisions within oncological care. She did Research in Oncology unit about assessing fatigue and activity intolerance in patients with cancer receiving treatment. She was a conference speaker at the 6th SEHA international Nursing, Midwifery and Allied health conference last September 2017 Abu Dhabi. She presented in EIOC in 2019 , 9th EOC in 2021. She is also a committee member of the Nursing Midwifery education & Research Unit (NMERU) at Tawam Hospital and is completing a Quality Improvement Project aimed at standardizing central line care and management. Currently she is the Lead of Oncology Educational Nursing advisory Group. "

Dr. Katie Sweeting

Specialist Palliative Care , Mediclinic City Hospital | United Arab Emirates

Dr. Katie completed specialist training in London and South East England to become a consultant in palliative medicine in 2009, working in both acute hospital and hospice settings. She has extensive experience of managing symptoms, concerns and expectations of patients with advanced cancer and other life-limiting illnesses. She is accredited by the Royal College of Physicians (UK) as both an educational supervisor and mentor.

Mr. Khaled Al Qawasmeh

Clinical Research Nurse , Tawam Hospital | United Arab Emirates

Khaled Al Qawasmeh qualified with Master’s Degree in Clinical Oncology Nursing from the University of Pennsylvania, Philadelphia, USA. He is an Oncology Certified Nurse (OCN) since 2009. Khaled has gained the prestigious Clinical Research Certification by SOCRA USA. Khaled is currently the president of the Emirates Oncology/Hematology Nursing Society.

Dr. Khalid Saeed Balaraj

Chair of Oncology Service , Tawam Hospital | United Arab Emirates

Dr. Khalid Balaraj was initially trained in the United Kingdom. He has radiation oncology qualifications from - UK (FRCR (I), Ireland (FFR RCSI) and Canada (FRCPC). He has done 2 Clinical Fellowships from Canada, in Gynecology Brachytherapy and CNS Stereotactic Radiotherapy. He has worked as an Assistant Professor in Al Faisal University, Riyadh, as well as Consultant of Radiation Oncology, for 7 years, treating patients on the latest technology, including IMRT, IGRT, Tomotherapy, Rapid Arc and Cyber- Knife at King Faisal specialist Hospital, Riyadh. Dr. Balaraj has treated patients on international RTOG trials. He has been General Secretary of the Saudi Cancer Society and Oncology Advisor for the CME Oncology Program Middle East. Joined Tawam hospital as a chairman of Radiation oncology department on September 2011 Currently he is an assistant professor at UAE University and the chairman of Tawam hospital Oncology Services and the chair of oncology service line at SEHA.

Mr. Khalid Al Habaybia

Nurse Manager, Paediatric Haematology-Oncology Unit , Tawam Hospital | United Arab Emirates

Khalid is currently a Acting Nurse Manager within the Paediatric Haematology-Oncology Unit at the Tawam Hospital, United Arab Emirates. Prior to this, Khalid graduated from the Faculty of Nursing at the University of Jordan in Amman, Jordan before going on to obtain a Master’s of Science in Healthcare Administration at the University of Atlanta in the USA. He actively participates in many haemophilia-focussed groups, taking on the role of Nurses Committee Member for the World Federation of Haemophilia (WFH), and General Secretary and Haemophilia Nurse at the United Arab Emirates Haemophilia Group, recently chosen as WFH World Congress Ambassador 2020. Khalid is also the Chairperson for the Nursing Care Working Group initiated by the Paediatric Oncology Eastern Mediterranean (POEM) Group, which aims to continuously improve paediatric oncology care, research, training and advocacy in the eastern and Mediterranean region by means of integrated teamwork.

Dr. Layla Al Reyami

Pediatrician , SEHA | United Arab Emirates

Dr. Layla Al Reyami is a pediatrician at SEHA who graduated from Gulf Medical University.

Dr. Lina Wahba

Clinical Pharmacy Lead , Tawam Hospital | United Arab Emirates

Dr. Lina Wahba is a clinical pharmacy lead and she also works as an adjunct lecturer at the Faculty of Medicine and Health Sciences, United Arab Emirates University. She earned her BSc in Pharmacy from the Faculty of Pharmacy, Jordan University of Science and Technology-Jordan, then had her MSc degree in Clinical Pharmacy from UCL, school of pharmacy/UK. She conducted her clinical training at Barts’ and the London NHS hospital trust-London. Lina is board certified oncology pharmacist. She maintains a primary clinical practice in Tawam oncology unit, and leading the Medication use evaluation committees. Lina has been having a major role in optimizing patient care in addition to creating and updating the oncology protocols. During her career, Lina worked as a clinical pharmacist in different institutions. She established the clinical pharmacy services in the paediatric oncology ward at King Hussein cancer centre- Amman/Jordan. She has many publications in addition to different abstracts that had been presented in the UK clinical pharmacy association conference, the American Society of Health System Pharmacists association (ASHP), Emirates Oncology Conference, and in the Journal of Oncology Pharmacy Practice (JOPP). Finally, Lina is the principal pharmacist in a number of Phase III multinational RCTs which are involving investigational chemotherapeutic and targeted agents.

Mr. Mahmoud Abdul Rahim Hasan

Assistant Director of Nursing , Tawam Hospital | United Arab Emirates

Mahmoud is the Assistant Director of Nursing for Oncology, Medical, Surgical, Al Wagan Hospital, and Regional Blood Bank at Tawam Hospital (UAE). He graduated from the Makkassed National College of Nursing, Lebanon in 2001 with a Bachelor of Sciences in Nursing and he completed his Master degree in Healthcare Management from the Royal College of Surgeons in Ireland in Dubai (RCSI-Dubai) in June 2010. He is an Oncology Certified Nurse by the Oncology Nursing Society (ONS, USA). Mahmoud chaired all the annual nursing sessions in the Emirates Oncology Conference from 2013 till today. He participated in a lot of activities to improve patient quality of care such as introducing the new appointment system in the oncology Clinic at Tawam Hospital (2010), introducing the new Medical Assessment & Planning Unit (MAPU) in 2017, End of life Outreach Nurse project (2017), Discharge project (2017-2018), Oncology Nurse Navigator program (2017) and Oncology Nurse Triage project (2018). He also work with oncology nursing team at Tawam hospital to conduct number of oncology nursing researches such as improving oral chemotherapy compliance in Oncology Clinic (2017), improving patient experience with Chemotherapy-induced nausea and vomiting (CINV), Tawam Experience (2017) and Assessing the Patient Education needs of Thalassemia Patients taking Iron chelating factors, Experience of Tawam hospital adult hematology/oncology department in the UAE (2018).

Prof. Mahmoud Marashi

Consultant Haematologist , Mediclinic City Hospital | United Arab Emirates

"Prof. Mahmoud Marashi joined Mediclinic City Hospital as Consultant Haematologist with over 30 years experience in haematology. He established the clinical haematology service in Dubai Health Authority which is involved in the management of both benign disorders (anaemias, bleeding disorders, thrombosis/thrombophilia) and malignant disorders (acute and chronic leukaemias, myeloma, myeloproliferative disorders, myelodysplastic syndrome). He runs both an undergraduate and postgraduate training in Haematology. Prof. Marashi did his undergraduate training in Andhra University, India. His haematology training was done in the UL at Heartlands Hospital, Birmingham, (formerly East Birmingham Hospital), The West Midlands Blood Transfusion Service, Edgbaston, Birmingham, The John Radcliffe Hospital and Chuchill Hospital in Oxford, UK. Prof. Marashi has been involved in medical education for over 20 years. He is a Professor of Medicine and Haematology and is the Head of the Academic Department of Medicine, Dubai Medical College / Dubai Health Authority. He is also an external examiner for the Royal College of Physicians of UK. *Independent Doctors (ID): Defined as individuals not employed by Mediclinic Middle East who are granted the privilege to treat patient at MCME facilities, in either inpatient or outpatient settings, as applicable."

Dr. Majed Al Ghamdi

Assistant Professor and Consultant Radiation Oncologist , Princess Norah Oncology Center | Saudi Arabia

Dr. Alghamdi, MD, MBA, FRCPC, DABR is an assistant professor and consultant radiation oncologist with a sub-specialization in treating central nervous system (CNS) tumors and stereotactic radiosurgery. He completed his residency training at university of Calgary, Alberta, Canada in 2016 and his fellowship training at university of Toronto, Ontario, Canada in 2017. He holds Canadian and American boards in radiation oncology. He has published three textbook chapters and numerous peer-reviewed manuscripts that mainly focused on CNS oncology. Recently, Dr. Alghamdi completed masters degree in business administration from prince Mohammad Bin Salman College of Business and Entrepreneurship.

Ms. Maricon Absalon

Acting Nurse Manager , Tawam Hospital | United Arab Emirates

"Maricon Absalon is working as Acting Nurse Manager in Oncology Unit and Palliative Care Unit of Tawam Hospital with an overall experience of 32 years .She is ONS certified. She joined Tawam in 2004 as a RN in Hematology unit. She has extensive experience and skills with various divisions within oncological care. She completed many Quality Improvement Project aimed at standardizing Clinical care in Oncology Division. "

Dr. Maroun Khoury

Consultant Oncologist/ Hematologist , American Hospital | United Arab Emirates

Assistant Professor Doctor Maroun El Khoury Consultant Oncologist/ Hematologist at American Hospital in Dubai 9/2010-Present. Mayo Clinic Network (Jci Accredited), Director Of Cancer Care Center, President of Medical Staff: 2018-2020. Chairperson Scientific Committee, Emirates Oncology Society: 2018-2020 .7/2006-8/2010: Private Practice In The Us/Iowa: Medical Director Of Oncology And Hematology Services And Chief Of Medicine At Great River Health System .7/2006-2010: Hospice Medical Co-Director .Epec (Education In Palliative And End-Of-Life Care) Trainer.

Prof. Marwan Ghosn

Professor and Chairman Hematology Oncology Department , Clemenceau Medical Center | United Arab Emirates

"Professor Marwan Ghosn acquired his medical degree and his post-graduate expertise in Hematology Oncology from Faculty of Medicine, Saint Joseph University in Beirut- Lebanon; as well as from the University of Paris XI, Le Kremlin Bicêtre and Institut Gustave Roussy Cancer Center in Villejuif- France. He is the Director of the Hematology Oncology Post-Graduate Program and the Chairman of the Hematology Oncology Department at Faculty of Medicine, Saint Joseph University in Beirut- Lebanon. He acquired a Master in Hospital and Health Management from The Higher School of Business, ESA in Beirut and a Master in the Quality Management of Units for Care Production (MUPS) from the University of Paris VII, Denis Diderot in France. He is currently the Director of the Cancer Center and the Head of Hematology Oncology Division at Clemenceau Medical Center affiliated with Johns Hopkins International in Beirut- Lebanon, and Consultant Medical Oncology at Clemenceau Medical Center in Dubai- United Arab Emirates."

Dr. Mawada Hussein

Medical Oncologist , UAE | United Arab Emirates

Medical Oncologist in United Arab Emirates

Dr. Meteb Foheidi

Medical Oncology Consultant , Princess Noorah Oncology Center | Saudi Arabia

Dr. Meteb Foheidi is a medical oncology consultant at Princess Noorah Oncology Center, National Guard Health Affairs, Jeddah, Asistant Professor & Medical Oncology Block Cordinator at King Saud Bin Abdulaziz University for Health and Science – Jeddah and Western Oncology Group Director, Saudi Oncology Society.

Prof. Michail Ignatiadis

Senior Attending Physician , Jules Bordet Institute | Belgium

"Michail Ignatiadis, MD PhD is senior attending physician at the Medical Oncology Department, Jules Bordet Institute (IJB) and associate professor at the Université Libre de Bruxelles, Belgium. Since January 2021, he is the chair of the breast cancer group of the EORTC. He is also leading the Academic Trials Promoting Team (ATPT) and he is member of the Executive and Research Boards of IJB since October 2016. He participates in developing the IJB research strategy. He works with his team and members of the Executive and Research Boards to promote high-quality, innovative, academic research at the institutional level. From June 2018 to January 2021, he served in the Board of Directors of the EORTC as the chair of the clinical research division. He has been involved in many investigator-initiated trials (IITs) sponsored by IJB at different stages of their development. He has been member of the Independent Data Monitoring Committees for international trials and study chair of several IITs. He served as IJB principal investigator for many industry sponsored trials. Currently, he is the study chair of the Alexandra/Impassion030 registration trial. He is particularly interested in drug and biomarker development in breast cancer. His work in the field of blood-based biomarkers is widely recognised at the international level. He has published more than 100 articles in peer reviewed journals including several papers in high impact factor journals such as Journal of Clinical Oncology, Nature Reviews Clinical Oncology, JAMA Oncology, Journal of National Cancer Institute, Lancet Oncology as well as several book chapters; he is editor of a book on minimal residual disease. He has served as reviewer for several national and international organisations including the French National Cancer Institute (INCA), the Technology Foundation STW in the Netherlands, the Marie-Curie Fellowships, the European Research Council (ERC) and the Innovative Medicines Initiative (IMI). He has served as Chair or Co-Chair of symposia in high visibility international conferences, organised by ESMO, ECCO and ASCO. He has served as faculty in the prestigious workshop ‘Methods in Clinical Cancer Research’ every year from 2014 until 2019. He has obtained independent research funding over the last 6 years."

Dr. Mikaela Olsen

Clinical Program Director for Oncology , Johns Hopkins Hospital | USA

"MiKaela M. Olsen, DNP, APRN-CNS, AOCNS®, FAAN, is the Clinical Program Director for Oncology at the Johns Hopkins Hospital and the Johns Hopkins Health System. Dr. Olsen serves as adjunct faculty for the Johns Hopkins School of Nursing and has a joint faculty appointment with the Johns Hopkins University. She is also a faculty Associate at the University Of Maryland School Of Nursing. Dr. Olsen received her Bachelor of Science in Nursing from Texas Christian University in Fort Worth Texas in 1989 and a Master of Science degree with special emphasis in Oncology nursing from the University of California at San Francisco in 1996. She graduated with her Doctor of Nursing Practice degree from University of Maryland in 2019. She is a certified Advanced Oncology Clinical Nurse Specialist. Dr. Olsen is co-editor of the ONS Safe Handling of Hazardous Drugs Guidelines (2018). She is currently the lead editor for the 1st edition of the Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (2019). She served on the American Society of Clinical Oncology (ASCO) and ONS Chemotherapy Safety Standards Workgroup (2016). She is the lead editor of the book “Hematologic Malignancies in Adults”, the first nursing textbook published to guide nurses in the care of hematologic malignancy patients. Dr. Olsen has published and extensively presented on the topic of safe handling of hazardous drugs. Working closely with the Institute for Safe Medication Practices (ISMP) as an expert advisory panelist, she has written recommendations for safe administration of chemotherapy and adult intravenous push medications. To increase nurses knowledge of the potential serious health risks associated with HD exposure, she assisted in the development of ONS continuing education (CE) courses. As an instructor and consultant, Dr. Olsen has traveled to countries including Singapore, UAE, China, Bulgaria, and Japan to increase awareness of HD exposure risks and safe handling. "

Dr. Mohammad Asha

Consultant Physician, Neurosurgery Clinics , Tawam Hospital | United Arab Emirates

Consultant Physician, Neurosurgery Clinics Tawam Hospital

Dr. Mohammad Hourani

Medical Oncologist , UAE | United Arab Emirates

Medical Oncologist at UAE

Mr. Mohammad Mah'D Saleh

Oncology Center Manager , Tawam Hospital | United Arab Emirates

Mr. Saleh is an Oncology Certified Nurse OCN with extensive clinical experience in oncology/hematology. After vast years of experience in nursing from a clinical educator, Nurse Manager and now being the Tawam Oncology Center Manager. He participates effectively in training and developing nursing staff. Mohammad has served as a Chemotherapy and Biotherapy Trainer since 2011 and was the first international trainer at the level of UAE. He was responsible for a variety of quality improvement initiatives and hospital quality measures such as central line associated blood stream infections (CLABSI), prevention of chemotherapy error, and improving the safe handling of hazardous drugs, and management of radiation therapy side effects based in the latest evidence based practice. Mohammad, actively participates in oncology service development and collaborate with others in setting the standards in cancer care and improve quality and cancer patient’s outcome through continuum of care, and customer services and be connected with local and international cancer centers.

Dr. Mohammed Al Nuaimi

Consultant Physician , Tawam Hospital | United Arab Emirates

"Dr. Mohammed Al Nuaimi is a consultant physician in Pediatric Hematology & Oncology, Bone Marrow Transplant and Cellular Therapy, at Tawam Hospital, Al-Ain, UAE. He completed his general pediatrics residency training, pediatric hematology & oncology fellowship & Bone Marrow Transplant and Cellular Therapy fellowship at The Hospital for Sick Children (SickKids) Toronto, Canada. Dr. Al Nuaimi holds the Canadian and American Boards of general pediatrics, and the Canadian board in Pediatric Hematology & Oncology. He has a special interest in bone marrow failure diseases, bone marrow transplant and celluar therapy. Dr. Al Nuaimi is a member of several professional societies including Children's Oncology Group (COG) and American Society of Hematology (ASH). He has completed and ongoing research activities and gave many talks in his speciality.

Dr. Mohammed Ashour

Consultant Medical Oncologist , Kuwait Cancer Control Center | Kuwait

Consultant Medical oncologist Kuwait cancer control center. Prof. Clinical Oncology Alzhar University. Cancer research diploma Harvard University. Member of ASCO and ESMO. Interested in GU&GY malignancy. Has many publications in peer review journal.

Dr. Mohanad Diab

Consultant Medical Oncology , Burjeel Hospital | United Arab Emirates

Dr. Mohanad Diab is an established and highly skilled Consultant Medical Oncologist with over 12 years of experience in the field of Oncology. He pursued his MD in 2004 from Karolinska University, Sweden. He obtained his Certification in Bone Marrow Transplantation in 2008 from Oncology Hospital, Radiumhemmet. Dr. Diab spent the first half of his career in the hospitals of the West Gotland Region, Sweden, as a Consultant Medical Oncologist. In 2014, he relocated to UAE and served eight years as the Head of the Oncology Department in one of the leading private hospitals in Abu Dhabi before joining Burjeel Hospital, Abu Dhabi. He is well regarded for his active involvement in setting up a world-class oncology clinic and multi-disciplinary tumor board. His expertise is treating distinctive cancers through chemotherapy, targeted therapy, and immunotherapy. The conditions include brain cancer, oligodendroglioma, pancreatic cancer, colorectal cancer, meningioma, prostate cancer, mixed gliomas, lung cancer, ependymoma, metastatic cancer, oral cancer, primitive neuroectodermal tumor, breast cancer, cervical and ovarian cancer. He is an active contributor to the research & studies dedicated to the field of oncology and tumor diagnosis.

Dr. Mona Tareen

Consultant in Palliative, Geriatric and Internal Medicine , American Hospital | United Arab Emirates

Dr. Mona Tareen is a Consultant in Palliative, Geriatric and Internal Medicine. She obtained her basic medical degree from Dhow Medical College, Karachi, Pakistan and completed her US Board Certification in Internal Medicine, Geriatrics Board Certification and Hospice and Palliative Medicine. She has worked as Palliative Medicine Consultant and Medical Director of Hospice and Palliative Care Program in the US and also served the Rush University Medical Center, Chicago, as Consultant Geriatrician.

Dr. Mouza Mohd Al Ameri

Consultant Physician, Oncology – Breast Care Center (Dep) , Tawam Hospital | United Arab Emirates

Mouza Al Ameri is a breast onco-plastic surgeon and assistant professor of surgery in UAE University and Tawam Hospital. She is passionate about breast cancer research, empowering breast cancer survivors and disseminate breast cancer awareness among society members.

Dr. Muhammad Faisal Khanani

Chief of Hematology/Oncology PEDS , Tawam Hospital | United Arab Emirates

Chief of Hematology/Oncology PEDS – Tawam Hospital

Dr. Muhammad Zafar Javed

Chief of Palliative Care Clinics , Tawam Hospital | United Arab Emirates

Chief of Palliative Care Clinics – Tawam Hospital

Dr. Mustafa Baroudi

Consultant Pediatric Oncologist Hematologist , NMC Royal Hospital | United Arab Emirates

Dr Mustafa Baroudi is a Consultant Pediatric Oncologist Hematologist at NMC Royal Khalifa City, Abu Dhabi, UAE.

Dr. Muwafak Salman

Division Chief - Urology Clinic - Medical Affairs , Tawam Hospital | United Arab Emirates

Dr. Muwafak Salman, Consultant Urology, Andrology, Infertility and Men’s Health and Chief of Urology Department at Tawam Hospital.⁣ Dr. Salman has more than 16 years of experience ,in addition to, being certified by the Arab Board of Medical Specialties, with specialization in Surgery and the European board of Urology. He has completed his fellowship from the Royal College of Surgeons in Ireland, as well as, being a member in the American Urological Association.⁣

Dr. Nadeem Pervez

Radiation Oncologist , Cross Cancer Institute | Oman

"Dr. Nadeem Pervez qualified in Radiation Oncologist from Ireland and Canada. He worked in Ireland, Canada and Middle East at various academic levels. He served as radiation oncologist at Cross Cancer Institute and Associate Professor at University of Alberta, Edmonton, Alberta, Canada. His clinical work includes treating cancer of various sites with emphasis on breast and prostate cancer. He was a prominent member of Prostate Cancer Brachytherapy seed implantation treatment in Canada. He is initiating Prostate Brachytherapy treatment in the Middle East. He co-chaired breast cancer group in Alberta and contributed to Alberta Breast Cancer Treatment guidelines. He was involved in invention of newer radiotherapy machines. Nadeem was actively involved in contributing to Resident Training program and Clinical Research Fellowship program in Radiation Oncology at the University of Alberta, Canada. He was awarded best teacher award from residents to acknowledge his contributions. He oversees research projects from international fellows. His residents and fellows later appointed at key academic, clinical and leadership positions across world. He was invited as scientific speaker in multiple countries. Nadeem is actively involved in clinical research. He was able to secure multiple competitive research grants from awarding agencies. He was leading investigator initiated studies and involved in multi-institutional cooperative group studies. He published multiple research articles in reputed journals. He served in institutional ethics committees, research funds granting agencies, medical student selection committees, oncology conference scientific committee and peer-reviewed several Oncology journals. He is founding member in establishing Middle East Society of Therapeutic Radiation Oncology (MESTRO). "

Dr. Nandan Shanbagh

Specialist in Radiation Oncology and Palliative Care , Neuro Spinal Hospital | United Arab Emirates

Dr Nandan Shanbhag is a specialist in Radiation Oncology and Palliative Care. After completing his Bachelor’s in Medicine and Surgery (MBBS) and Post Graduate degree in Radiation Oncology from India, he completed his diploma in Palliative Medicine at the University of Cape Town in South Africa. He has worked in several countries across the world and helped establish cancer departments in India, Botswana, Bahrain and Antigua and Barbuda. He holds special research interest in application of Machine Learning in Oncology and Palliative care. He also completed his Executive Masters in Business Administration and remains an active member at various societies related to Oncology.

Dr. Naser Alzein

Chief Division of pediatric hematology/oncology , Sheikh Khalifa Medical City | United Arab Emirates

Dr Naser is currently serving as Chief Division of pediatric hematology/oncology at Sheikh Khalifa Medical City (SKMC). Dr Naser joined SKMC in 2009. Before that, he served as the medical director of pediatric hematology/oncology at Blank Children’s Hospital in Des Moines, Iowa in the United States of America. He is an assistant professor of pediatrics/pediatric hematology/Oncology at Carver College of Medicine at the University of Iowa in the United States. Dr Naser completed his medical school from Jordan University of Science and Technology in Jordan in 1993, and then he did his PhD in Pediatrics at the University of Jordan. Dr Alzein, completed his training in the United States of America. He is double American board certified in Pediatrics and pediatric Hematology/Oncology. Dr Naser has major interest in Lymphoma and hematological malignancies, as well as benign hematology like hemoglobinopathies He is a 2 times winner of the American Society of Oncology (ASCO) Merit Award; for the best translational medicine research abstract in cancer genetic. In addition, he won the Lymphoma Spore Group Grant Award in 2005 for his work on DNA methylation in B cell Lymphomas. In addition, Dr Alzein won 3 times the Best Teaching Award from the Education Department at SKMC Dr Alzein, has great experience in bone marrow transplant and solid tumors as well. Dr Alzein has been a speaker in several International and regional meetings. He has multiple publications related to his field.

Dr. Norberto Santana

Chair of Thoracic Surgery , SSMC-Mayo Clinic | United Arab Emirates

Dr. Norberto is an experienced surgeon with a strong background in minimally invasive surgery, lung transplantation, hospital management, team leader, education, and translational research. He has recently joined SSMC-Mayo Clinic in Abu Dhabi as Chair of Thoracic Surgery. Previously, he was the Head of Thoracic Surgery and Lung Transplantation at one of the most prestigious hospitals in the Middle East, King Faisal Specialist Hospital & Research Center, ranked 76 worldwide. Here, he has set for the first time in the Kingdom of Saudi Arabia and the Middle East, the uniportal video-assisted thoracic surgery (VATS) program for lung resections, mediastinum, foregut, and pleural diseases, the uniportal VATS lung anatomical segmentectomy program in patients with lung cancer or centrally located lung metastasis to prevent the lobectomy, uniportal VATS decortication program to avoid the thoracotomy in patients with empyema, and the robotic thoracic surgery (RATS) program together with other novel programs such as: VATS cytoreductive surgery plus unidirectional hyperthermic intrathoracic chemotherapy (HITHOC) for patients with malignant pleural diseases (mesothelioma, thymoma, etc.), the introduction of ECMO and CBP for major airway and lung tumor resections, endoscopic closure of bronchopleural fistula, 3D reconstruction for personalized surgical treatment through the planning of lung sparing surgery, minimally invasive esophagectomy and chest wall tumors resection, periareolar biportal sympathetic chain clipping for patients with severe hyperhidrosis, submammary chest wall tumor resection and reconstruction and a VATS training program for fellows and residents.

Dr. Noura Aldhaheri

Assistant Professor at the Department of Pediatrics , College of Medicine and Health Sciences (CMHS) | United Arab Emirates

Noura AlDhaheri is an Assistant Professor at the Department of Pediatrics, College of Medicine and Health Sciences (CMHS), UAE University. Dr. AlDhaheri holds American Board of Pediatrics certification and is qualified in Medical Genetics & Genomics and Medical Biochemical Genetics. Dr. AlDhaheri obtained her pediatric residency training at Children’s National Medical Center in Washington DC, USA (2012-2015) then training in Medical Genetics from Johns Hopkins School of Medicine and National Institute of Health in the United States (2015-2017). Following that, she completed Medical Biochemical Genetics Fellowship at Baylor College of Medicine and Texas Children Hospital in Houston, TX, USA in November 2018 and joined CMHS- UAE University as an Assistant Professor. She is also a consultant Clinical Genetics and Medical Biochemical Genetics at Tawam Hospital, Al Ain. Dr. AlDhaheri’s current research focus is in Genomic Medicine. Specifically, rare disease and identification of novel genes for rare disease in several cohorts including: cleft lip/palate, VACTERL/VATER and vertebral malformation cohorts in an attempt to help “solve” Mendelian disorders for which the genetic etiology is presently unknown.

Dr. Nouri Bennini

Consultant Physician, Oncology Clinic , Tawam Hospital | United Arab Emirates

Dr.Nouri Bennini is a Consultant Physician, Oncology Clinic at Tawam Hospital.

Dr. Omar Bekdache

Consultant General Surgeon , Tawam Hospital | United Arab Emirates

"Omar A. Bekdache, MD, MSc, FRCS, FACS, EBSQ is a Consultant General Surgeon at Tawam Hospital – former Johns Hopkins affiliate, currently holding the position of Chief of Trauma Services and Chairman of Trauma Committee. Dr Bekdache obtained his medical degree from Lebanese University School of Medicine and residency training in General Surgery at the American University of Beirut Medical center and MGH. Dr Bekdache has completed a clinical fellowship in Minimal Invasive surgery from the University of Lille – France. He obtained in addition a University Diploma in Hepato-Biliary Surgery from the University of Paris XI – Paul Brousse Hospital / Villejuif Paris – France and completed the European Board of Surgical Oncology."

Dr. Omran El Koha

Consultant Radiation /Clinical Oncologist , Tawam Hospital | United Arab Emirates

Dr. Omran is an experienced clinical oncologist with a demonstrated history of working in the medical and radiation oncology p . Skilled in Clinical Research, Medical Education, Strategic Planning. Strong education professional with a Master's Degree focused in Health research ethics

Dr. Paul Kelly

Consultant Radiation Oncologist , UPMC Hillman Cancer Centre | Ireland

Dr Paul Kelly is a graduate of University College Cork and completed General Professional Training in medicine at the Mater Hospital, Dublin. Having acquired Membership of the Royal College of Physicians he completed specialist training in Radiation Oncology at St Luke’s Hospital in Dublin. He became a Fellow of the Faculty of Radiology at the Royal College of Surgeons in Ireland in 2008 and, thereafter, completed a 2-year Clinical Fellowship in Stereotactic Radiosurgery at Brigham and Women’s Hospital/Dana-Farber Cancer Institute in Boston, Massachusetts. Based in Cork since 2011 as a Consultant Radiation Oncologist he is active in clinical research and co-chairs the GU disease-specific subgroup (DSSG) of Cancer Trials Ireland. His chief interests include prostate cancer, brain tumours, stereotactic radiotherapy and prostate seed brachytherapy. He took up a position as Medical Director of the new radiation oncology facility at the Bon Secours Radiotherapy Centre joint venture with University of Pittsburgh Medical Centre (UPMC) Hillman Cancer Centre in 2019.

Dr. Paul Sanghera

Clinical oncology consultant and honorary lecturer , University Hospitals Birmingham, UK | United Kingdom

Following clinical oncology training in London and Birmingham, Paul undertook a brain tumour fellowship with The University of Toronto. Paul returned to The UK in 2008 and was appointed a clinical oncologist at University Hospitals Birmingham. Paul has had a busy clinical Neuro-Oncology practice since this appointment. He led the radiotherapy department between 2013 and 2018, and then the neuro-oncology tumour board from 2018. Paul is the current regional brain tumour research lead and expert advisory group chair. Paul has been an investigator on several brain tumour studies, served on trial management groups, published widely and supported national research groups working to develop new clinical trials

Prof. Rami Mahfouz

Tenured Professor and Head of Division of Clinical Pathology , AUBMC | Lebanon

"Earned his medical degree from the American University of Beirut followed by a Clinical Pathology residency and a Fellowship in Molecular Pathology at St Jude Children’s Research Hospital in Memphis, Tennessee focusing on HLA and molecular diagnostics and microarrays technology in research. In 2002, he joined the Department of Pathology and Laboratory Medicine at the American University of Beirut Medical Center as Assistant Professor and worked since then on establishing a Molecular Diagnostics Laboratory with a service scope covering different specialties including Transplantation, Molecular Microbiology, and Molecular Pathology. His major research interests include Natural killer cell immunoglobulin-like receptors (KIR) genotyping, HLA associations, and cancer profiling. He has 198 publications and serves as Associate and Executive editor on several international journals including GENE and META GENE. He is currently a Tenured Professor and Head of Division of Clinical Pathology in the Department of Pathology and Laboratory Medicine at AUBMC and the Director of the Histocompatibility and Molecular Diagnostics Laboratory, Director of the Residency Training Program, and Chairman of the Biomedical Institutional Review Board. He is a member of several international and professional societies including the College of American Pathologists (CAP), the American Society of Histocompatibility and Immunogenetics (ASHI), and the American Association of Molecular Pathologists (AMP) where he is serving as the Chairman of its International Affairs Committee."

Dr. Rana Mahmood

Consultant Oncologist , Mediclinic City Hospital | United Arab Emirates

Dr Rana Mahmood trained in UK and has been a consultant in oncology for last 15 years. Dr Mahmood has special interest in advance image guided radiotherapy, SABR and image based High Dose rate Brachytherapy. He is the first to introduce and only practitioner to provide Gynaecological interstitial brachytherapy in UAE. He has setup the only service in UAE to provide prostate Brachytherapy and trans-perineal spacer device. He has been principal investigator for several landmark radiotherapy trials and extensively published his work.

Dr. Rehan Saif

Consultant General Surgery , Burjeel Medical City | United Arab Emirates

Dr. Rehan Saif is an experienced Consultant General & Hepato-Pancreato-Biliary/Abdominal Multi-Organ Transplant Surgeon (Liver/Pancreas/Kidney) at Burjeel Medical City, Abu Dhabi. He completed his MBBS and MS (General Surgery) from JJM Medical College, India. His interest in the field of HPB/GI Surgery and Abdominal Multi-Organ Transplantation led him to the United Kingdom where he spent a total of 13 years gaining further Specialist Higher Surgical Training with a National Training Number leading on to CCT (UK). He is a UK and European Board certified HPB and Abdominal Multi-Organ Transplant Surgeon. He has also completed numerous fellowships in Minimally Invasive Robotic HPB/GI Surgery and Complex Liver Surgery and Transplantation.

Prof. Rob Jones

Director, CRUK Clinical Trials Unit , Beatson West of Scotland Cancer Centre | United Kingdom

Professor Jones is Director, CRUK Clinical Trials Unit, Beatson West of Scotland Cancer Centre. After undergraduate training at the Universities of Oxford and Edinburgh, Rob moved to Glasgow to train in internal medicine and then Medical Oncology. He completed PhD in the Frame Lab at the Beatson Institute for Cancer research, where he studied the role of Src kinase in metastatic progression. From 2003 to 2005 he was seconded to the department of Experimental (Discovery) Medicine at Alderley Park (AstraZeneca plc) where he provided translational medicine input to a number of early oncology projects in the invasion and metastasis biological effect area.

Dr. Saad Ghazal Aswad

Gynecological Oncologist , Tawam Hospital | United Arab Emirates

"Dr. Aswad obtained his MD from Aleppo University, Syria in 1980. Subsequently, he did his post-graduate training in O&G in the UK and became a Member of the Royal College of Obstetricians and Gynecologist in 1988 and a Fellow in 2000. He pursued further subspecialty training in Gynecological Oncology (Gateshead, UK) and obtained his Ph.D. from the University of Newcastle Upon-Tyne, the UK in 1994. Prior to moving to the UAE, he was a Senior Consultant in the Northern Region of England and Lecturer at the University of Newcastle Upon-Tyne, UK. Over the last fifteen years, Dr. Aswad has been providing nationwide Gynecological Oncology Services in Tawam Hospital, UAE. In recognition of his significant contribution to maternal health issues in UAE, Dr. Aswad was awarded distinction Fellowship of the Faculty of Public Health of the Royal Colleges of Physicians of United Kingdom. Apart from the FFPH, he was awarded the Clinical Service Distinction Award (CMHS, UAEU), Best Department Award in UAE Hospitals (Sheikh Hamdan Bin Rashid Al-Maktoum Award for Medical Sciences), Outstanding Contribution to Medical Education in the Middle East (Arab Health) and many other UK national awards. Dr. Aswad has more than sixty full papers and abstracts published in National and International Medical Journal and Conference Proceedings, four book chapters and nine educational videos. Dr. Aswad is an active member of many National and International Scientific Societies."

Dr. Sadir Alrawi

Consultant Surgical Oncology , Burjeel Holdings | United Arab Emirates

Dr. Alrawi is currently the Director of Oncology Services at Burjeel Holdings in the UAE and MENA. He oversees tertiary referral cancer centers for the entire UAE and palliative care and research. Dr. Alrawi was the Director of Oncology Services (Surgery and Oncology) at Alzahra Hospital in the heart of Dubai and the hospital’s tertiary referral cancer center for the entire UAE, where he oversaw highly specialized surgical oncology subspecialties such as colorectal, breast, head and neck, urology, gynecological, sarcoma/melanoma, and peritoneal surface mal From October 2013 to September 2015, Dr. Alrawi served as Chief of the Surgical Oncology Division at Tawam Hospital and Interim Chair of the Department of Surgery. John Hopkins Medical System is affiliated with Tawam Hospital. Dr. Alrawi’s primary area of interest is gastrointestinal oncology, which encompasses esophageal, gastric, pancreas, liver, colonic surgery, and endocrine surgery, including thyroid, parathyroid, and adrenal surgery. Dr. Alrawi received his surgical oncology training at various academic institutions throughout the country, including Roswell Park Cancer Institute in Buffalo, the Royal Free Hospital at the University of London, and Ninewells Hospital at the University of Dundee. Dr. Alrawi is an American Board-Certified physician who completed his Head and Neck Surgery and Surgical Oncology Fellowships at Roswell Park Cancer Institute (NCI) in 2006. Dr. Alrawi trained in advanced laparoscopic oncology from 1992 to 1993 with Professor Alfred Cuschieri in Dundee, advanced colorectal oncology from 1993 to 1995 with E Lloyd Davis in Cornwall, England, and advanced surgical oncology from 1995 to 1996 with Professor Marc Winslett in London. He has received numerous academic honors during his training and clinical practice years. He is a frequently invited speaker at public and professional meetings devoted to cancer management education. Throughout his career, Dr. Alrawi has been involved in various research activities to increase our understanding of cancer early detection and multidisciplinary approaches. Dr. Alrawi has published over 50 papers in peer-reviewed journals and over 150 presentations at local, national, and international meetings in clinical and basic sciences throughout his 30-year career in surgical oncology. He has also authored ten book chapters. Dr. Alrawi is committed to community outreach and firmly believes that cancer care and health awareness, combined with excellence in cancer diagnosis and treatment delivered by a multidisciplinary team, can and will save lives.

Ms. Salwa Al Saedi

Speech and Language Pathologist , Tawam Hospital | United Arab Emirates

Salwa is a speech and language pathologist working under SEHA Al Ain region. Salwa completed her bachelor degree in general linguistics in 2008 at UAE University. In 2012, Salwa gained her first master degree in Applied Linguistic form the University of Sydney, Australia. Two years later, Salwa completed her second master degree in Speech and language pathology at the same university. Post master degree completion, Salwa resumed working at Tawam Hospital providing both inpatient and outpatient services, and taking part in HAAD and SEHA SLP committee. At the moment, Salwa is working as a supervisor SLP across two facilities (Tawam and Al Ain hospital) providing acute care services and outpatient services with main focus in head and neck oncology.

Dr. Selvaraj Giridharan

Consultant Physician, Oncology Clinic , Tawam Hospital | United Arab Emirates

Dr Selvaraj Giridharan is a highly skilled and experienced oncologist with dual accreditation from the UK. He completed his Bachelor’s Medical degree from the University of Madras in 1993 and went on to continue his training in the UK, he became a member of Royal college of Physicians in 1998 and then achieved clinical oncology Fellowship in 2004. He worked as a consultant clinical oncologist in University Hospitals of North Midlands from 2004 to 2022 until his appointment to Tawam Hospitals in September this year. During his time in Stoke he held several additional roles including being services lead, audit lead, research lead, appraiser and clinical tutor. He has published extensively and has been a PI and SI for more than 30 clinical trials.

Dr. Shahrukh Hashmi

Chairman , SEHA Oncology Council | United Arab Emirates

"Dr. Shahrukh Hashmi is the acting Dean of Research at SSMC, Abu Dhabi, UAE. He graduated from Baqai Medical University, Pakistan, as the top graduate receiving Gold Medal from the President of Pakistan. He received Master’s Degree (MPH) from Yale University, Connecticut, USA. He is a Diplomat of the American Board of Preventive Medicine/Public Health, Internal Medicine, and Hematology. He has been at Mayo Clinic, Minnesota, USA for >10 years. He started Mayo Clinic’s first BMT survivorship program. He has served as PI or Co-PI on many industry-sponsored and NIH sponsored trials. His research interests include premature aging, artificial intelligence, and GVHD. He is also involved in Stem Cell Therapeutics particularly in regenerative hematology. He has authored >220 articles in peer-reviewed journals, including in JAMA, Lancet, and in NEJM. He chairs many national or international professional committees/groups including being the chair of the Worldwide Network for Blood and Marrow Transplant’s Nuclear Accident committee (Geneva, Switzerland), founding chair of American Society for Blood and Marrow Transplant Society’s Survivorship SIG (Chicago, Illinois), and co-chair of the Center for International Blood & Marrow Transplant Registry’s (CIBMTR) Health Services Committee (Milwaukee, Wisconsin). He is currently the chairperson of the Dept. of Hematology/Oncology at the SSMC, Abu Dhabi, UAE, and the chairperson of SEHA Oncology Council. He is also faculty at Khalifa University, UAE, and adjunct faculty at Mohamad Bin Zayed University of Artificial Intelligence, UAE."

Dr. Shilpi Roy

Medical Oncologist , UAE | United Arab Emirates

Medical Oncologist at UAE

Dr. Sibylle Loibl

Chief Executive Officer , GBG Forschungs GmbH | Germany

"Prof. Dr. Sibylle Loibl is Chair of the German Breast Group and the Chief Executive Officer of the GBG Forschungs GmbH. Prof. Dr. Loibl is an associate professor of obstetrics and gynaecology at the Goethe University of Frankfurt. She gained a doctorate at the Ruprecht Karl University of Heidelberg and trained as a consultant in gynaecology and obstetrics at the women’s clinics of the university hospitals in Heidelberg and Frankfurt am Main. She devotes most of her time to clinical research within the German Breast Group and clinical work at the Centre for Haematology and Oncology, Bethanien in Frankfurt. Prof. Dr. Loibl has gained international renommée for her research in neoadjuvant breast cancer, breast cancer during pregnancy and breast cancer in young women. She established the Translational Research Group within the German Breast Group and has headed numerous research projects. In addition, Prof. Dr. Loibl has been involved in conducting and managing a significant number of national and international, practice-changing clinical trials. Prof. Dr. Loibl is author of more than 400 original and peer-reviewed articles and scientific papers; she has written numerous books and book chapters. She is an active member of many important national and international organizations, such as ASCO, ESMO, DKG and the AGO. She is involved in national and international guidelines for breast cancer, amongst them those for ESMO and ASCO. She was the first Co-Chair of the ESMO Breast Conference in Berlin and is an active faculty member of many international (ASCO, ESMO, SABCS) conferences."

Dr. Stephanie Ricci

Consultant Gynecologic Oncologist , Oncology Institute at Cleveland Clinic | United Arab Emirates

"Stephanie Ricci, MD is an Assistant professor of OB GYN at the Lerner College of Medicine at the Cleveland Clinic and a Consultant Gynecologic Oncologist in the Oncology Institute at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Ricci was an Assistant professor of OB GYN in the division of Gynecologic Oncology at the Cleveland Clinic. Dr. Ricci received her medical degree from the University of Connecticut School of Medicine in the USA, where she also completed her residency in Obstetrics and Gynecology. Following residency, Dr. Ricci completed a Fellowship in Gynecologic Oncology at Johns Hopkins Hospital, USA. Throughout her tenure, Dr. Ricci has specialized in gynecologic oncology completing over 3000 operations from minimally invasive surgery to cytoreductive surgeries with heated intraperitoneal chemotherapy. Her research interests have focused mainly on clinical patient care including rare uterine tumors, time to treatment and survivorship in women with gynecologic cancer. During her last six years at Cleveland Clinic in Ohio she served as the Gyn lead for the uterine transplant program which is the largest deceased donor program in the world. "

Dr. Stephen Grobmyer

Institute Chair of the Oncology , Cleveland Clinic | United Arab Emirates

"Dr. Stephen R. Grobmyer, MD, is the Institute Chair of the Oncology Institute at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Grobmyer was Professor of Surgery, Section Head of Breast Surgery and Co-Director of the Cleveland Clinic Comprehensive Breast Cancer Program at Cleveland Clinic Main Campus in Cleveland, Ohio. Dr. Grobmyer received his medical degree from the University of Texas Southwestern Medical School in Dallas, Texas and completed his residency in General Surgery at New York Hospital-Cornell Medical Center in New York. He completed a fellowship in Surgical Oncology at Memorial Sloan Kettering in 2004. Dr. Grobmyer™s innovative clinical care and research focuses on developing new approaches to prevent, diagnose and treat breast cancer. He has published over 170 peer-reviewed manuscripts, twenty book chapters and edited a textbook on innovative cancer therapies. Additionally, he has given over one hundred invited lectures nationally and internationally. "

Dr. Sulaman Magdub

Histopathology Consultant , Tawam Hospital | United Arab Emirates

Acting chief of Hisopatology at Tawam Hospital. Experienced Consultant with a history of working in the hospital & health care industry. Skilled in Medical Diagnostics, Healthcare Information Technology (HIT), Healthcare Management, Healthcare, and Clinical Research. Strong consulting professional with a Doctor of Medicine - MD focused in Medicine from Al Arab Medical University.

Dr. Suliman Al Ghamdi

Head , King Abdullah International Medical Research Center, Western Region | Saudi Arabia

"Dr. Suliman Al Ghamdi joined King Abdulaziz Medical City, Western Region in August 2005 as Associate Consultant, Department of Oncology, and promoted to Consultant position in 2007 and was appointed as Section Head, Radiation Oncology in August 2007. In August 2010, he was appointed as Deputy Chairman, Princess Noorah Oncology Center, King Abdulaziz Medical City, Western Region. In August 2011 till August 2020, he was appointed as Head, King Abdullah International Medical Research Center, Western Region. Dr. Suliman Al Ghamdi graduated from King Abdulaziz University, Faculty of Medicine, Jeddah, Saudi Arabia in 1997, and completed his internship in the same institution in 1998. He completed his Residency Training Program in Radiation Oncology from January 2000 till December 2004 at Ottawa Regional Cancer Centre, University of Ottawa, Ontario, Canada, followed by fellowship training in Radiation Oncology with sub - specialization in Stereotactic Radiosurgery of Head and Neck, CNS Malignancies and Brachytherapy in 2005. He also obtained FRCPC certificate on May 28, 2004. "

Ms. Sumeya Al Hammadi

Manager of Rehabilitation Services , Tawam Hospital | United Arab Emirates

Ms Sumeya Mohammed Al Hammadi , manager at Al Ain Region Rehabilitation Department has extensive 17 years professional experience in the field of Rehabilitation . Graduated from University of Sharjah in 2006 , Sumeya is practicing as an expert physiotherapist dealing with different clinical conditions. She is an expert Lymphedema therapist, certified & trained in Germany, Foeldi Clinic. Ms Sumeya is a speaker, a researcher and a successful leader in Alain region.

Prof. Syed Hussain

Professor and Consultant in Medical Oncology , University of Sheffield | United Kingdom

"Professor Hussain graduated from Dow Medical College Karachi in 1994. He completed his general medical professional training in UK. He did his Doctorate in Oncology from University of Birmingham. He then completed his Medical oncology training in Birmingham, United Kingdom and received his certification and specialist registration in Medical oncology. Professor Hussain is Professor and Consultant in Medical Oncology at the University of Sheffield and Sheffield Teaching Hospitals NHS Trust. His major areas of interest are management of urological cancers, clinical trials, early drug development and translational medicine. He has set up large number of clinical trials from early phase to late phase studies during his career. His work on organ preservation in bladder cancer moved all the way from an early phase I study (Hussain et al Annals of Oncology 2001) to phase II efficacy study (Hussain et al BJC 2004) that led to a Cancer Research UK funded study BC2001 trial that was reported in New England Journal of Medicine (James, Hussain, Hall et al April 2012). This study has now changed the standard of care for patients with muscle invasive bladder cancer opting for organ preservation treatment. Professor Hussain is principal investigator of number of studies in urological cancers. He is a chief investigator of a national randomised placebo-controlled phase II neo-adjuvant study in muscle invasive bladder cancer. He served as chief investigator of various early phase trials, and translational studies. Professor Hussain has authored over 105 peer-reviewed publications including 4 book chapters in textbooks of oncology. His Google scholar H-index is 37 with over 8300 citations. He has published in high impact journals including New England Journal of medicine, Lancet, Lancet Oncology, JAMA, JAMA Oncology, Journal of Clinical oncology, European Urology, Annals of Oncology, Nature communications, Clinical Cancer Research, British journal of Cancer. He has been an invited speaker to number of national and international meetings. Professor Hussain has secured funding of over 10 million pounds from funding bodies. "

Dr. Syed Tirmazy

Consultant Clinical Oncologist , Dubai Hospital | United Arab Emirates

"Dr Syed Hammad Tirmazy is a Consultant Clinical Oncologist and Head of Oncology at Dubai Hospital, DHA. He has substantive experience in managing adult solid cancers and has been involved in multiple international clinical trials. Before moving to Dubai in 2016, he was working as Consultant Clinical Oncologist in west midlands region UK. After completing his graduation, he moved to UK in 2003, he initially completed internal medicine training and MRCP and subsequently attained training in Clinical Oncology and worked in internationally renowned oncology centers in UK including Queen Elizabeth Hospital Birmingham. He completed Master’s in Clinical Oncology from university of Birmingham, FRCR Clinical Oncology from RCR London and has CCT in Clinical Oncology. He also attained FRCP Glasgow. "

Dr. Syed Zubair

Consultant Medical Oncologist , King Faisal Specialist Hospital | Saudi Arabia

He is a Consultant Medical Oncologist at the King Faisal Specialist Hospital and Research Centre in Jeddah and have specialist interest in the management of colorectal, prostate and CNS tumors.He completed his post graduate medical education in the UK and trained as a medical Oncologist at the Yorkshire Deanery leading to a CCT in Medical Oncology. he initially worked as a Consultant Medical Oncologist at St James University Hospital in Leeds and then spent nearly a decade at the James Cook University Hospital in the North East of UK prior to moving to Jeddah. He has been involved in recruiting many patients to various phase 2 and phase 3 clinical trials during my career and currently the chairman of the Oncology Mortality and Morbidity committee at KFSHRC in Jeddah

Dr. Syed Mansoor Hasnain

Consultant Radiation Oncologist , Tawam Hospital | United Arab Emirates

"Dr. Syed Mansoor Hasnain is working in Tawam Hospital, Alain, UAE as Consultant Radiation Oncologist. He joined Tawam Hospital in 2009. He initially trained as surgeon and did fellowship in surgery ,FRCS(Glasg) from Royal College Of Physicians and Surgeons Of Glasgow in 2000. In 2001 he started his career and specialist registrar Training in radiation Oncology under supervision of Faculty of Radiology, The Royal College Of Surgeons In Ireland in Saint Luke’s Hospital. He passed FRCR part 1 from Royal College of Radiologists, London U.K. He did fellowship in radiotherapy ‘FFR RCSI’ from Faculty of Radiology , Royal College Of Surgeons In Ireland in 2007. In 2010 he got CCST 'completion of certified specialist training certificate’ from Faculty of Radiology, The Royal College Of Surgeons In Ireland and entry in to specialist register in Medical Council of Ireland. In Tawam in early 2011, Dr. Mansoor successfully led the commissioning and clinical use of the HiArt TomoTherapy system with IMRT & IGRT, one and only in UAE. . In 2013 Dr. Mansoor chaired RapidArc committee, making sure smooth and swift implementation of RapidArc technology with IMRT & IGRT capability in Tawam. In 2015 Dr. Mansoor was appointed as Adjunct Assistant Professor in College of Medicine and health Sciences in UAE University. . In 2018 as lead radiation oncologist, he successfully led the QUATRO certification of the radiotherapy department by IAEA. He is clinical lead Radiation oncologist for Lymphoma, Sarcoma, Urology & GI tumours. "

Dr. Taif Sarraj

Chief of Clinical Support Services , Tawam Hospital | United Arab Emirates

"Taif S. Al Sarraj, Ph.D., M.Sc., RD., is the Chief of Clinical Support Services for three major hospitals (Tawam, AlAin, and AlWagan hospitals) within the AlAin Region of the Emirate of Abu-Dhabi. Previously served as Deputy COO at Shaikh Khalifa Medical City (SKMC), and as an Adjunct Assistant Professor at the UAE University’s Faculty of Medicine and Health Sciences. Dr Taif Al Sarraj has 25 years of extensive experience in healthcare leadership, operation, and performance management. In addition to quality and patient safety, JCI accreditation, and disasters' incident commanding. On the other hand, she has experience in clinical researches, academic education, continues clinical education, national and international conferences organization and participation, health education and public health awareness and contribution through community out-reach activities, awareness lectures, and media interviews via national media programs. Dr Al Sarraj is a Fellow Candidate of the American College of Healthcare Executives (ACHE). She had successfully led and manage the clinical support services as well as hospital operation activities throughout her leadership and rotation experience across SEHA hospitals. She participated in COVID-19 pandemic's disaster management, commissioning of MBZ field hospitals, and AD Covid-19 designated hospital. Dr Al Sarraj is the recipient of The Abu Dhabi Medical Distinguish Award (Department of Health - 2011); The SEHA Nursing & Allied Health leadership Award (SEHA in 2013); The Emirates Women Award (Dubai Quality Group in 2012), The UAE Rare Diseases Society Excellence Award (UAE Genetic Diseases Association 2017); The Shaikh Rashid Award for Academic Superiority (The UAE Culture & Scientific Association, twice in 2011 and 1997); Dr. Robert G. Jensen Award for Excellent Research in Nutritional Sciences (University of Connecticut 2009). In 2020, Dr. AlSarraj was awarded the Distinguished Alumni Award by the University of Connecticut, College of AHNR, for her distinguished contributions to the Healthcare sector in UAE. Dr. AlSarraj excelled in clinical nutrition. Her research interests are in the area of pathophysiology of metabolic syndrome, and diabetes complications, glucose and lipid metabolism, inflammation markers and vascular complications. Voluntary Activities: -Ambassador of Abu-Dhabi Public Health Center -Chair of Medical Unit within the Al Ain Group- for the preparation of FIFA U-17 World Cup (17th Oct- 8th Nov 2013 United Arab Emirates)"

Dr. Tarek Benashur

Consultant Breast Imaging Radiologist , Tawam Hospital | United Arab Emirates

Tarek Benashur, Tripoli, Norht Africa Consultant Breast imaging radiologist German Facharzt 2001 EDBI 2015 MBBS 1987 Head of the radiology in Breast care Center Tawam H. Al Ain, UAE

Ms. Theresa Binz

Manager of Radiation Therapy , Tawam Hospital | United Arab Emirates

Theresa Binz Qualified in 1999 as radiation therapist at the Cape Peninsula University of Technology (CPUT) in Cape Town, South Africa. Soon after, she worked 2 years in Germany followed by 2 years in The Netherlands, where she furthered her studies in radiotherapy. After returning back to South Africa, she completed both the BTech and Master’s degree at CPUT, achieving, Suma Cum Laude for her Master’s degree. In South Africa she worked for 10 years at a Groote Schuur Hospital where she specialised in radiation therapy planning. She has been on a variety of expert missions as representatives of the IAEA, to provide clinical skills training, lectures and site evaluations. She has been part of the development of the Access to Care program in Cape Town (varian skills training platform), and a part time lecturer at CPUT. Currently she is the manager of Radiotherapy at Tawam Hospital in Al Ain, Abu Dhabi, United Arab Emirates.

Dr. Thikra A M Hassan

Chief of Oncology-Obs. And Gyno , Tawam Hospital | United Arab Emirates

Chief of Oncology-Obs. And Gyno. – Tawam Hospital

Dr. Tim Benepal

Consultant Medical Oncologist , St Georges Healthcare NHS Trust | United Kingdom

Dr. Tim Benepal is a BSc, MB BS, FRCP, PhD, Consultant Medical Oncologist and Honorary Senior Lecturer at St Georges University Hospitals NHS Trust, London, UK

Dr. Trent Hummel

Associate Professor of Clinical Pediatrics , University of Cincinnati College of Medicine | USA

Dr. Hummel's clinical and academic interests pertain to children and families affected by central nervous system tumors. He focuses on developing novel therapeutics to treat children with all central nervous system tumors including those patients with neurofibromatosis type 1 and 2 related CNS tumors and very poor prognosis tumors such as high-grade gliomas and diffuse intrinsic pontine glioma.

Dr. Vivek Muthu

Managing Director , Marivek Healthcare Consulting | United Kingdom

A company founder experienced in health systems, life sciences and business leadership and management, Dr Vivek Muthu originally worked as a physician in the UK, including at London's Queen Square, the Hammersmith and Oxford University hospitals. He then joined the British Medical Journal, where he helped to develop and lead a team examining the clinical evidence on safety and efficacy of drugs and devices. During that time he also co-authored a popular handbook for junior doctors. He went on to found Bazian, a company dedicated to developing and servicing the needs of the emerging paradigm of value-based health internationally, focusing on the application of research, data and evidence on ensuring that health services and technologies deliver high quality, safe, cost-effective care. Having sold and integrated Bazian into the Economist Group to create its healthcare practice, Vivek took executive leadership and strategic responsibility for the business globally and continues to consult for the business. He additionally holds non-executive and advisory roles in healthcare companies in the health policy, biotech and data spaces and is additionally involved in international initiatives in health systems improvement and sustainability. Areas of focus include access and adoption of novel and sophisticated biotechnologies, principally in oncology, in an increasingly challenging healthcare and payer environment dominated by concerns around budget impact, population health value and financial sustainability.

Dr. Yasser Farahat

Chairman , Arab School of Urology | United Arab Emirates

"Dr. Yasser Farahat currently serves as Professor of Urology at Tanta University, Egypt, a Clinical Tutor at Edinburg University, UK, and a Fellow of the Royal College of Surgeons, UK. He is a Consultant Urologist at the Ministry of Health and Prevention UAE and a Fellow of the European Board of Urology (FEBU). He is acting as a Senior Consultant of Urology at Sheikh Khalifa General Hospital (SKGH-UAQ), UAE. His special interests & research include minimally invasive surgery, Endo-urology, Robotic Assisted FURS, Reconstructive Urology, and Andrology. He completed his MD in 2004 at Tanta University, Egypt. He had been awarded several prizes including the Best Research and Presentation at The First Eastern Mediterranean Meeting of European Association of Urology in 2007 and The Best Research Poster Presentation at the 25th annual EAU Congress in 2010. He is one of the worldwide initiators of using the robotic-assisted RIRS since the invention of the Roboflex and improving the utilization of flexible ureteroscopy in renal calculi management. He is also, a reviewer of several international journals. He has published over 35 international and local publications and has presented at 90 conferences worldwide. Dr. Farahat is an active member of many international urological associations and societies including, The European Association of Urology (EAU), Société Internationale D’Urologie (SIU), Endourological Society and he is currently the head of the scientific committee of Emirates Urological Society (EUS), Cochair of the scientific committee of Urological Association of Asia (UAA), Secretary-General of Arab Association of Urology (AAU) and Chairman of Arab School of Urology. "

Dr. Zainul Aabideen

Consultant Paediatric , Burjeel Medical City | United Arab Emirates

"Dr. Zainul is a highly skilled and experienced in Paediatric Haematology and Oncology. He received his Degree in Medicine at Calicut University in Kerala, India, subsequently he took his Post - Graduate degree in Paediatrics from the University of Mumbai. In 2001, Dr. Zainul moved to the United Kingdom where he specialize and undertake further training and experience in paediatric haematology, paediatric oncology and Paediatric Bone Marrow Transplantation in various hospitals in UK. Dr. Zainul gained his master’s degree in Paediatric Oncology at Birmingham University as well as Certificate in Medical Education at Manchester University. Subsequently, he completed his International Fellowship in Paediatric Bone Marrow Transplantation at Great North Children’s Hospital in Newcastle. He worked previously as Consultant Pediatric at University Hospital of Coventry and Warwickshare and Royal Oldham Hospital before moving to UAE. In the UAE, He had worked at Department of Pediatric hematology and Oncvology Tawam Hospital as Consultant, Al Ain, before he joined at Burjeel Medical City. Aside from his commitment to further advance his experience and knowledge in the field of Paediatrics, Paediatric Haematology, Oncology and Bone Marrow Transplantation in the United Kingdom he also published numerous articles and actively support by sharing his knowledge to the community by participating international conference across countries."

Dr. Zuhdi Khalid

Consultant, Gyn oncology , Latifa Hospital | United Arab Emirates

Consultant, Gyn oncology, Latifa Hospital

Dr. Zulfaqqar Ali

Oncologist/Haematologist , Mediclinic Middle East | United Arab Emirates

Dr. JaffarAli trained at Columbia University/Roosevelt Hospital, New York and gained his Fellowship in Haematology and Oncology from New York Medical college, St. Vincent's Hospital. He is triple American board certified in Internal Medicine, Haematology and Medical Oncology. He practised in the USA as an Oncologist/Haematologist for more than 15 years prior to moving back to the UAE and has particular interests in breast cancer, cutting edge oncology treatments such as immunotherapy and genetic predisposition to cancers. He has been involved in clinical research in multiple cancers and has published and presented at the American Society of Clinical Oncology. He is a member of the American Society of Oncology.